75000 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - Condensed Consolidated Balance Sheets (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - Condensed Consolidated Statements of Operations (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - Condensed Consolidated Statements of Operations (Unaudited) 2
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Statement - Condensed Consolidated Statements of Stockholders' Equity / (Deficit) (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75060 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75070 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - Nature of Operations and Basis of Presentation
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Liquidity and Going Concern
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - Acquisitions
link:presentationLink
link:calculationLink
link:definitionLink
995485 - Disclosure - Fair Value Measurements
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Balance Sheet Components
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Goodwill and Intangible Assets
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Public Offering
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - Private Placement
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - Income Taxes
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - Debt
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - Sorrento Stock Purchase Agreement and Equity Line of Credit
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Stockholders' Deficit
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - Stock Incentive and Employee Benefit Plan
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Variable Interest Entities
link:presentationLink
link:calculationLink
link:definitionLink
995605 - Disclosure - Restatement of Previously Issued Financial Statements
link:presentationLink
link:calculationLink
link:definitionLink
995615 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - Related Party Transactions
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - License Agreements
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - Net Loss Per Share
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - Subsequent Events
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - Nature of Operations and Basis of Presentation (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - Nature of Operations and Basis of Presentation (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - Summary of Significant Accounting Policies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995695 - Disclosure - Fair Value Measurements (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995705 - Disclosure - Balance Sheet Components (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - Goodwill and Intangible Assets (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Debt (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - Stock Incentive and Employee Benefit Plan (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - Commitments and Contingencies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Income Taxes (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995765 - Disclosure - Net Loss Per Share (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995775 - Disclosure - Restatement of Previously Issued Financial Statements (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - Nature of Operations and Basis of Presentation (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995795 - Disclosure - Liquidity and Going Concern (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - Summary of Significant Accounting Policies (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of condensed balance sheets
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of the calculation of basic and diluted net income per ordinary share
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Acquisitions (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Public Offering (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Private Placement (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995865 - Disclosure - Commitments and Contingencies (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995875 - Disclosure - Fair Value Measurements (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995885 - Disclosure - Fair Value Measurements (Details) - Schedule of fair value liabilities measured on a recurring basis
link:presentationLink
link:calculationLink
link:definitionLink
995895 - Disclosure - Fair Value Measurements (Details) - Schedule Of The Derivative Liabilities Measured at Fair Value
link:presentationLink
link:calculationLink
link:definitionLink
995905 - Disclosure - Fair Value Measurements (Details) - Schedule of The Inputs Used In Valuing The Derivative Warrant Liabilities
link:presentationLink
link:calculationLink
link:definitionLink
995915 - Disclosure - Balance Sheet Components - Summary of financial data for investments accounted for under the equity method of accounting (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995925 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995935 - Disclosure - Balance Sheet Components - Schedule of Acrcued expenses - Details (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995945 - Disclosure - Balance Sheet Components - Schedule of Adjustment Gross to Net Revenue (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995955 - Disclosure - Balance Sheet Components - Schedule of accrued rebates (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995965 - Disclosure - Balance Sheet Components - Schedule of consolidated balance sheet (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995975 - Disclosure - Balance Sheet Components - Schedule of digital assets (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995985 - Disclosure - Balance Sheet Components (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995995 - Disclosure - Goodwill and Intangible Assets (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996005 - Disclosure - Goodwill and Intangible Assets - Summary of identifiable intangible assets (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996015 - Disclosure - Goodwill and Intangible Assets - Estimated future amortization expense of intangible assets (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996025 - Disclosure - Debt (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996035 - Disclosure - Debt - Schedule of Convertible Debenture (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996045 - Disclosure - Debt - Schedule of the Oramed Note (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996055 - Disclosure - Debt - Schedule of the Tranche B Note (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996065 - Disclosure - Debt - Schedule of FSF Deposit (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996075 - Disclosure - Debt - Schedule of revenue liability activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996085 - Disclosure - Debt - Schedule of aggregate principal amount of our long-term debt maturing (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996095 - Disclosure - Sorrento Stock Purchase Agreement and Equity Line of Credit (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996105 - Disclosure - Stockholders' Deficit (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996115 - Disclosure - Restatement of Previously Issued Financial Statements (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996125 - Disclosure - Restatement of Previously Issued Financial Statements (Details) - Schedule of impact of these adjustments to the financial statement, as previously reported
link:presentationLink
link:calculationLink
link:definitionLink
996135 - Disclosure - Stock Incentive and Employee Benefit Plan (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996145 - Disclosure - Stock Incentive and Employee Benefit Plan - Schedule of Stock Options Outstanding Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996155 - Disclosure - Stock Incentive and Employee Benefit Plan - Schedule of Stock Options Valuation Assumption Used (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996165 - Disclosure - Variable Interest Entities (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996175 - Disclosure - Commitments and Contingencies - Schedule of Components of Lease Expense (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996185 - Disclosure - Commitments and Contingencies - Schedule of Leases Supplemental Quantitative Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996195 - Disclosure - Commitments and Contingencies - Schedule of Lease Maturities of Lease Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996205 - Disclosure - Commitments and Contingencies - Schedule of Lease Maturities of Lease Liabilities (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
996215 - Disclosure - Commitments and Contingencies (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996225 - Disclosure - Net Loss Per Share - Schedule of the reconciliation of basic and diluted loss per share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996235 - Disclosure - Net Loss Per Share - Potentially dilutive outstanding securities were excluded from the computation of diluted net loss per share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996245 - Disclosure - Net Loss Per Share (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996255 - Disclosure - Acquisitions - Summary of fair value of the total purchase consideration (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996265 - Disclosure - Acquisitions - Summary Of Estimated Fair Value Of The Net Assets acquired And Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996275 - Disclosure - License Agreements (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996285 - Disclosure - Subsequent Events (Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
Conversion of Tranche B Notes into Common Stock
Conversion of Tranche B Notes into Common Stock
Conversion of Tranche B Notes into common stock
Schedule of Leases Supplemental Quantitative Information
Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]
Weighted Average Exercise Price, Forfeited/Cancelled
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
Q Scan Note [Member]
Q Scan Note [Member]
QScan Note
Unrecognized Incremental Stock Based Compensation Expense
Unrecognized Incremental Stock Based Compensation Expense
Unrecognized incremental stock-based compensation expense
Segments [Domain]
Gloperba-Elyxyb Royalty Purchase Agreement [Member]
Gloperba-Elyxyb Royalty Purchase Agreement [Member]
Payments to Acquire Receivables
Amount paid for purchased receivables
Amount paid for purchased receivables
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest, Total
Loss from operations
Deferred consideration
DeferredConsiderationLiabilities
DeferredConsiderationLiabilities
Concentration Risk Type [Axis]
Stock Options
Stock Options [Member]
Stock Options [Member]
Finance lease liabilities
Finance Lease, Liability
Finance Lease, Liability, Total
Schedule of the derivative liabilities measured at fair value using significant unobservable inputs Level 3
Schedule of Derivative Liabilities at Fair Value [Table Text Block]
Shareholders Equity Details Line Items
Shareholders' Equity (Details) [Line Items]
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Preferred stock, shares issued
Preference shares issue
Preferred Stock, Shares Issued
A-1 Preferred Stock
A-1 Preferred Stock [Member]
A-1 Preferred Stock [Member]
Statement of Financial Position Location, Balance [Domain]
Employee benefit plan contributions by employer
Defined Benefit Plan, Plan Assets, Contributions by Employer
Commitments and Contingencies [Line Items]
Commitments and Contingencies [Line Items]
Revision of Prior Period [Axis]
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Supplemental disclosure of non-cash financing activity
Common stock sold
Common stock sold.
Common stock sold
Common stock sold
Proceeds from (Repayments of) Notes Payable
Promissory note issued
Crypto Asset, Activity [Line Items]
Plan Name [Axis]
Retainer Shares Issued Value
Retainer shares issued value
Retainer Shares Issued Value
Senior Subordinated Notes [Member]
FSF Deposit
Entity Current Reporting Status
Entity Current Reporting Status
Proceeds from Warrant Exercises
Proceeds from warrant exercises
Proceeds from exercise of December 2024 RDO Warrants
Price Per Share Payable
Price Per Share Payable
Price Per Share Payable
Accrued Royalty Payables
Accrued Royalty Payables
Accrued Royalty Payables
Public Offering Details Table
Public Offering (Details) [Table]
Operating Expenses [Abstract]
Net operating costs and expenses:
Definitive Agreement With Phoenix Asia Holdings Limited [Member]
Definitive Agreement With Phoenix Asia Holdings Limited [Member]
Definitive Agreement With Phoenix Asia Holdings Limited [Member]
Deferral Fee Per Share
Deferral Fee Per Share
Deferral fee per share
Investment Received as Non Cash Consideration
Investment Received as Non Cash Consideration
Vivasor Equity Method Investment received as non-cash consideration
Level 2 [Member]
Fair Value, Inputs, Level 2 [Member]
February 2024 BDO Representative Warrants [Member]
February 2024 BDO Representative Warrants [Member]
February 2024 BDO Representative Warrants
November 2025 Warrants [Member]
November 2025 Warrants [Member]
November 2025 Warrants [Member]
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
A-2 Preferred Stock [Member]
A-2 Preferred Stock [Member]
A-2 Preferred Stock
Tien-Li Lee Member
Tien-Li Lee Member
Tien-Li Lee [Member]
Common stock, shares authorized
Ordinary shares, authorized
Common Stock, Shares Authorized
Share-Based Payment Arrangement, Tranche Three [Member]
Tranche Three
Finite-Lived Intangible Asset, Expected Amortization, Year Four
2029
Crypto Asset [Domain]
Series One Preferred Stock [Member]
Series One Preferred Stock [Member]
Series 1 Preferred Stock [Member]
Shares issued under Standby Equity Purchase Agreements and under ATM Sales Agreement, Share
Shares issued under Standby Equity Purchase Agreements and under ATM Sales Agreement
Shares issued under Standby Equity Purchase Agreements and under ATM Sales Agreement
Schedule Of Condensed Balance Sheets Abstract
Schedule of condensed balance sheets [Abstract]
Lessee Operating Lease Liability Payments Due After Year Four
Lessee Operating Lease Liability Payments Due After Year Four
Thereafter
Investment, Policy [Policy Text Block]
Datavault Investment
Repurchase Of Warrants
Repurchase of warrants.
Repurchase Of Warrants
Product and Service [Axis]
Document Fiscal Period Focus
Debt Instrument, Description
Debt instrument, description
Instrument-specific Credit Risk [Member]
Instrument-specific Credit Risk [Member]
Instrument-specific Credit Risk [Member]
Acquisition consideration paid in cash for Romeg intangible asset acquisition
Acquisition Consideration Paid In Cash for Romeg Intangible Asset Acquisition
Acquisition Consideration Paid In Cash for Romeg Intangible Asset Acquisition
Acquisition consideration paid in cash for Romeg intangible asset acquisition
Other Noncurrent Liabilities [Member]
Other Noncurrent Liabilities
Other long term assets
Assets, Noncurrent, Other than Noncurrent Investments and Property, Plant and Equipment
Preferred Stock, Convertible, Conversion Price, Decrease
Reduction in the exercise prices
Entity Shell Company
Entity Shell Company
Accrued rebates and fees
Other Accrued Liabilities, Current
Other accruals
Total accrued rebates and other sales-related accruals
Accrued rebates and fees
Convertible Debentures Scilex-St. James Loans [Policy Text Block]
Convertible Debentures Scilex-St. James Loans [Policy Text Block]
Scilex-St. James Loans
Issuance of common stock upon warrants exercise
Issuance of Common Stock Upon Warrants Exercise, Value
Issuance of Common Stock Upon Warrants Exercise, Value
Current portion of deferred consideration
Current portion of deferred consideration
Current portion of deferred consideration
Convertible Debt [Member]
Convertible Debentures [Member]
Convertible Debentures
Stock Issued During Period, Value, Purchase of Assets
Number of shares purchase amount
Segments
Segment Reporting, Policy [Policy Text Block]
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value, Total
Cash – Beginning of period
Cash – End of period
Cash and Cash Equivalent
Accrued Datavault License
Accrued Datavault License
Accrued Datavault licenses
RDO Common Warrants
RDO Common Warrants [Member]
RDO Common Warrants [Member]
VIE [Member]
VIE [Member]
VIE [Member]
Related Party Transactions
Related Party Transactions [Policy Text Block]
Related Party Transactions [Policy Text Block]
Repayment of Tranche B Notes
Repayment of Tranche B Notes
Repayment of Tranche B Notes principal and interest
Repayment of Tranche B Notes principal and interest
Condensed Financial Information Disclosure [Abstract]
Agreement settlement payment
Litigation Settlement, Fee Expense
Subsidiary, Sale of Stock [Line Items]
Marketable Securities [Member]
Marketable Securities [Member]
Marketable Securities [Member]
Sales Discount Percentage
Sales Discount Percentage
Sales discount percentage
Research and Development Arrangement, Contract to Perform for Others, Type [Axis]
Offer and sell shares of Common Stock
Ordinary shares issued
Common Stock, Shares, Issued
Common stock, shares issued
Number of Treasury Stock transferred to Tranche B Investors for Tranche B Note deferral Shares
Number of Treasury Stock transferred to Tranche B Investors for Tranche B Note deferral Shares
Treasury Stock transferred to Tranche B Investors for Tranche B Note deferral, Shares
Yorkville and B. Riley [Member]
Yorkville and B. Riley [Member]
Yorkville and B. Riley [Member]
Rodman & Renshaw LLC
Rodman & Renshaw LLC [Member]
Rodman & Renshaw LLC [Member]
Upfront Fee Payable Under License Agreement Contingent Amount
Upfront fee payable under license agreement contingent amount.
Upfront fee payable under license agreement contingent upon the achievement of specified development, regulatory, and commercial milestone
Statement [Table]
ROU assets obtained in exchange for new operating lease liabilities
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Closing Price Of Pledged Securities Percent
Closing Price Of Pledged Securities Percent
Closing Price Of Pledged Securities Percent
AOCI Including Portion Attributable to Noncontrolling Interest [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Options granted weighted-average grant date fair value
Datavault [Member]
Datavault [Member]
Datavault [Member]
Payments to Acquire Businesses, Gross
Shares issued under Registered Direct Offering
Shares Issued During Period, Values, Registered Direct Offering
Shares Issued During Period, Values, Registered Direct Offering
Processing Units Infrastructure
Processing Units Infrastructure
Processing Units Infrastructure
Five Installment [Member]
Five Installment [Member]
Five Installment [Member]
Statement [Line Items]
Business Combination [Domain]
Payments On Purchased Revenue Liability
Payments On Purchased Revenue Liability
Payments on purchased revenue liability
Six Installment [Member]
Six Installment [Member]
Six Installment [Member]
Envelta [Member]
Envelta Member
Debt Repayment, Percentage of Mandatory Default Rate of Principal Amount
Debt Repayment, Percentage of Mandatory Default Rate of Principal Amount
Debt repayment, percentage of mandatory default rate of principal amount
Warrant Distributions [Member]
Warrant Distributions [Member]
Warrant Distributions [Member]
Implementation fee of First Year
Implementation fee of First Year
Implementation fee of First Year
Public Warrant [Member]
Warrant [Member]
Warrant
Denali underwriters [Member]
Denali underwriters [Member]
Denali underwriters [Member]
Entity Filer Category
Entity Filer Category
Variable Interest Entity Disclosure [Text Block]
Variable Interest Entities
Commitment Amount
Common Stock, Value, Outstanding
Commitment Amount Payable
Commitment Amount Payable
Commitment Amount Payable
Shares Purchased Under Stock Purchase Agreement
Shares Purchased Under Stock Purchase Agreement
Shares Purchased Under Stock Purchase Agreement
Allocation of net income (loss), as adjusted
Temporary Equity, Net Income
Total liabilities and stockholders' deficit
Total liabilities and stockholders' equity/(deficit)
Liabilities and Equity
Begning Balance of Stockholders Deficit
Ending Balance of Stockholders Deficit
Gain (Loss) on Disposition of Stock in Subsidiary
Realized gains on sales of stock
Debt Instrument [Line Items]
Debt Instrument [Line Items]
2028
Long-Term Debt, Maturity, Year Three
Weighted Average Exercise Price, Exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Long-Lived Tangible Asset [Axis]
Repricing Options [Member]
Repricing Options [Member]
Repricing Options
Business Combination, Assets Held For Sale
Business Combination, Assets Held For Sale
Assets held for sale
Semnur Business Combination Agreement [Member]
Semnur Business Combination Agreement [Member]
Semnur Business Combination Agreement Member
Business Combination, Voting Equity Interest Acquired, Percentage
Noncontrolling interest in VHC, Percentage
Noncontrolling interest, Percentage
Treasury Stock transferred to Oramed for the Oramed Note maturity extension
Treasury Stock transferred to Oramed for the Oramed Note maturity extension
Treasury Stock transferred to Oramed for the Oramed Note maturity extension
Deferred Revenue [Domain]
Proceeds from Issuance of Debt
Proceeds from issuance of Tranche B Notes and purchased revenue liability
Pledged Securities Shares
Pledged Securities Shares
Pledged Securities Shares
Plus Abstract
Plus:
PlusAbstract
Extinguishment of Debt, Amount
Amount extinguished and reduced
Debt outstanding balance
Financing service fee
Financing Service Fee Percentage
Financing Service Fee Percentage
Shares Issued, Price Per Share
Price Per Share
Stock purchase price
Subsequent Event [Line Items]
Deferral Modification
Deferral Modification
Deferral Modification
Documents Incorporated by Reference [Text Block]
Documents Incorporated by Reference
Goodwill
Goodwill
Goodwill, Ending Balance
Goodwill, Beginning Balance
Goodwill, Total
Sorrento [Member]
Sorrento [Member]
Sorrento [Member]
Agency fees expense
Agency fees expense
Agency fees expensed - purchase of Datavault shares
Convertible Debentures [Member]
Convertible Debt Securities [Member]
Convertible Debt Securities [Member]
At-the-Market Sales Agreement [Member]
At-the-Market Sales Agreement [Member]
At-the-Market Sales Agreement
Shares issued under Bought Deal Offering
Shares issued under Bought Deal Offering, value
Shares issued under Bought Deal Offering, value
Royalty Payments Percentage
Royalty Payments Percentage
Purchase Agreement [Domain]
Purchase Agreement Domain
FutureTech Capital LLC [Member]
FutureTech Capital LLC [Member]
FutureTech Capital LLC [Member]
Payments to Acquire Intangible Assets
Purchases of Bitcoin
Shares Purchased Under Securities Purchase Agreement
Shares Purchased Under Securities Purchase Agreement
Number of shares purchase
Common Stock Share Purchases
Common Stock Share Purchases
Common Stock Share Purchases
Exercise Pre-Funded warrant increased in percentage ownership
Exercise Pre Funded Warrant Increased In Percentage Ownership
Exercise Pre Funded Warrant Increased In Percentage Ownership
Private Placement [Member]
Private Placement Warrant [Member]
Private Placement Warrant [Member].
PrivatePlacementWarrantMember
Variable Interest Entity [Table]
Treasury Stock, Preferred [Member]
Treasury Stock [Member]
Private Placement Disclosure Textblock
PRIVATE PLACEMENT
PrivatePlacementDisclosureTextblock
Stock Dividend Declared And Canceled
Stock dividend declared and canceled.
Stock dividend declared in 2024, and canceled in February 2026
Accounts Receivable, Allowance for Credit Loss
Accounts Receivable, Allowance for Credit Loss, Ending Balance
Accounts Receivable, Allowance for Credit Loss, Beginning Balance
Allowances for expected credit losses accounts receivable
Fourth Installment [Member]
Fourth Installment [Member]
Fourth Installment [Member]
Debt Issuance Costs, Net
Received in cash
Debt Issuance Costs, Net, Total
Non-refundable license fee Payable
Non-refundable license fee Payable
Change In Fair Value Of Debt And Liability Instruments
Change In Fair Value Of Debt And Liability Instruments
Change in fair value of debt and liability instruments
Change in fair value of debt and liability instruments
Debt Instrument, Interest Rate During Period
Debt instrument, interest rate
Loan interest rate
Maximum Borrowable Amount
Maximum Borrowable Amount
Maximum borrowable amount
Ordinary shares issued (in Shares)
Excess Stock, Shares Issued
Related Party
Related Party [Member]
Conversion of Stock, Amount Converted
Conversion of common stock
Conversion of Stock, Amount Converted
Repayment of FSF Deposit
Repayment of Deposit
Repayment of Deposit
Debt Instrument Outstanding Principal
Debt instrument outstanding principal
Outstanding debt instrument
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Significant Accounting Policies [Text Block]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment [Line Items]
Royalty Rate Percentage
Royalty Rate Percentage
Royalty Rate Percentage
Finite-Lived Intangible Asset, Useful Life
Finite Lived Intangible Asset Useful Life
Semnur [Member]
Semnur [Member]
Semnur [Member]
Schedule of Cash and Cash Equivalents
Schedule of Cash and Cash Equivalents [Table Text Block]
Vesting [Domain]
Preferred Stock, Redemption Amount
Shares amount
Issuance of Common Stock Under Bought Deal Offering Warrants
Issuance of Common Stock Under Bought Deal Offering Warrants
Issuance of Common Stock Under Bought Deal Offering Warrants
Proceeds Received from Purchase Agreement
Proceeds Received from Purchase Agreement
Proceeds received from purchase agreement
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Options Outstanding, Granted
Schedule of the reconciliation of basic and diluted loss per share
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Digital Assets [Policy Text Block]
Digital Assets [Policy Text Block]
Digital Assets
Equity Investment [Member]
Equity Securities [Member]
Senior Notes, Total
Senior Notes
Oramed Note
Outstanding Principle
Investment, Name [Axis]
Loss per share, Basic
Basic (Loss) income per ordinary share
Basic (Loss) income Per Share
Loss per share attributable to common stockholders - basic
Shares issued under Bought Deal Offering
Shares issued under Bought Deal Offering, Share
Shares issued under Bought Deal Offering, Share
Derecognized the Carrying Value
Derecognized the Carrying Value
Derecognized the carrying value
Change in Fair Value of Tranche B Notes
Change in Fair Value of Tranche B Notes
Change in fair value of Tranche B Notes
Business Combination, Right-Of-Use Assets
Business Combination, Right-Of-Use Assets
Right-of-use assets
Number of option outstanding to purchase common stock
Options Outstanding, Ending Balance
Options Outstanding, Beginning Balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Stock dividend declared in 2024, and canceled in February 2026, (shares)
Stock dividend declared, not yet distributed, Shares
Stock dividend declared, not yet distributed, Shares
Investor Agreement [Member]
Investor Agreement [Member]
Investor Agreement [Member]
Recognized Incremental Stock Based Compensation Expense
Recognized Incremental Stock Based Compensation Expense
Recognized incremental stock-based compensation expense
Debt, Policy [Policy Text Block]
The Oramed Note and Tranche B Notes
Debt
license Fee
license Fee
license Fee
Variable Interest Entity [Line Items]
Pledged Securities
Pledged Securities
Pledged Securities
Total current liabilities:
Liabilities, Current
Total current liabilities
Scilex Pharma Notes [Member]
Scilex Pharma Notes [Member]
Accounts receivables, net
Accounts receivables, net
Increase (Decrease) in Accounts Receivable
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]
Adjustments to reconcile net loss to net cash proceeds from operating activities:
Collateralized of Share
Collateralized of Share
Collateralized of Share
Elyxyb Rest of World License Agreement [Member]
Elyxyb Rest Of World License Agreement [Member]
Elyxyb Rest Of World License Agreement [Member]
Accrued expenses
Business Combination, Recognized Liability Assumed, Accrued Expenses, Current
Business Combination, Recognized Liability Assumed, Accrued Expenses, Current
Exercise price
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price
Scilex Stockholders Deficit [Member]
Scilex Stockholders Deficit [Member]
Scilex Stockholders Deficit [Member]
Sale of Datavault AI Inc. Shares for Cash
Sale of Datavault AI Inc. Shares for Cash
Sale of Datavault shares for cash, net
Adjustment of Fair Value Oramed Note Unaudited
Adjustment of Fair Value Oramed Note Unaudited
Adjustment of Fair Value of Oramed Note unaudited
Increase Decrease in Other Liabilities
Increase Decrease in Other Liabilities
Other liabilities
Business Combination, Recognized Liability Assumed, Other Liability, Noncurrent
Development milestones payment was recognized under other long-term liabilities
December Common Warrants Two Point Five Year [Member]
December Common Warrants Two Point Five Year
December Common Warrants Two Point Five Year [Member]
Gross proceeds
Gross Proceeds
GrossProceeds
Private Placement Details Table
Private Placement (Details) [Table]
Payments of debt issuance costs
Payments of Debt Issuance Costs
Payments of debt issuance costs
Other Liabilities, Current [Abstract]
Other current liabilities:
Common Warrants [Member]
Common Warrants [Member]
Common Warrants
Reverse Stock Split
Reverse Stock Split [Policy Text Block]
Reverse Stock Split [Policy Text Block]
Equity, Attributable to Parent [Abstract]
Stockholders' deficit:
Securities Borrowed
Securities Borrowed, Total
Company borrowed amount
Entity Small Business
Entity Small Business
Accumulated deficit
Retained Earnings (Accumulated Deficit), Total
Accumulated deficit
Accumulated Deficit
Retained Earnings (Accumulated Deficit)
Issue of warrants
Issue of Warrants to Purchase Shares
Issue of Warrants to Purchase Shares
Accretion Expense
Non-cash accretion of the discount
Preferred Stock [Member]
Preferred Stock [Member]
Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]
Entity Well-known Seasoned Issuer
Entity Well-known Seasoned Issuer
Proceeds from Issuance Initial Public Offering
Net cash proceeds for direct offering
Price per share (in Dollars per share)
Sale of Stock, Price Per Share
Sale of Common Stock per share
PA OPS Investor LLC [Member]
PA OPS Investor LLC [Member]
PA OPS Investor LLC Member
Total intrinsic value of option exercise
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value
Sales and Excise Tax Payable, Current
Excise tax liability
Convertible Promissory Note [Member]
Convertible Promissory Note [Member]
Convertible Promissory Note [Member]
Number Of Share Outstanding
Number Of Share Outstanding
Number Of Share Outstanding
Acea Therapeutics [Member]
Acea Therapeutics [Member]
Acquisition of Controlling Interest
Acquisition of Controlling Interest
Acquisition of controlling interest in Vivasor
Share-Based Payment Arrangement [Text Block]
Sorrento Stock Purchase Agreement and Equity Line of Credit
Purchased Revenue Liability
Purchased Revenue Liability
Purchased revenue liability
Beginning Balance
Ending Balance as of March 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Estimated Sales Returns and Discount [Member]
Estimated Sales Returns and Discount [Member]
Estimated sales returns, discounts, co-payment assistance and coupon [Member]
Aggregate Amortization Expense
Aggregate Amortization Expense
Subsequent Penny Warrants 1 [Member]
Subsequent Penny Warrants 1 [Member]
Subsequent Penny Warrants 1 [Member]
Amendment Flag
Amendment Flag
Proceeds from Received Net Cash
Proceeds from Received Net Cash
Change in fair value of purchased revenue liability
Change in Fair Value of Purchased Revenue Liability
Change in Fair Value of Purchased Revenue Liability
Product and Service [Domain]
Schedule of The Tranche B Note [Table Text Block]
Tavular disclosure of The Tranche B Note Table Text Block
Schedule of the Tranche B Note
Accrued Advisor Fees
Accrued Advisor Fees
Accrued advisor fees related to Semnur Business Combination
Fee Warrant issued in connection with the Commitment Letter
Fee Warrant issued in connection with the Commitment Letter
Fee Warrant issued in connection with the Commitment Letter
Aggregate purchase of private placement warrants (in Shares)
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Warrants exercisable
Satisfaction Agreement
Satisfaction Agreement Member
Satisfaction Agreement [Member]
Earnings Per Share, Policy [Policy Text Block]
Net Loss per Share
September 2025 Warrants [Member]
September Two Thousand Twenty Five Warrants [Member]
September Two Thousand Twenty Five Warrants [Member]
Datavault Securities Purchase Agreement [Member]
Datavault Securities Purchase Agreement [Member]
Datavault Securities Purchase Agreement [Member]
LIABILITIES AND STOCKHOLDERS' DEFICIT
Liabilities and Equity [Abstract]
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Accounts Receivable, Net
Accounts Receivable [Policy Text Block]
Net cash proceeds from (used for) operating activities
Net cash used in operating activities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Net cash proceeds from operating activities
Debt Instrument, Redemption Price, Percentage
Redemption Premium
Redemption price percentage
Datavault Warrants [Member]
Datavault Warrants [Member]
Common Stock [Member]
Common Stock [Member]
Common Stock [Member]
Accrued Liabilities for Commissions, Expense and Taxes
Accrued Liabilities for Commissions, Expense and Taxes
Business Combination, Recognized Asset Acquired, Inventory, Current
Inventory
2026 (remaining nine months)
Long-Term Debt, Maturity, Year One
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Weighted Average Exercise Price, Granted
Scilex Pharma [Member]
Scilex Pharma
Scilex Pharma [Member]
Scilex Pharma [Member]
Lessee, Operating Lease, Liability, to be Paid, Year Three
2029
Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]
Schedule of significant unobservable inputs (Level 3)
Less: Accumulated depreciation
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total
Payments to Acquire Interest in Joint Venture
Acquisition of controlling interest in Vivasor
Denominator Abstract
Denominator:
DenominatorAbstract
Public Offering Details Line Items
Public Offering (Details) [Line Items]
Probudur [Member]
Probudur Member
Junior DIP Facility [Member]
Junior DIP Facility [Member]
Junior DIP Facility [Member]
Purchase of Shares
Purchase of shares
Purchase of Class B shares
Crypto Asset, Number of Units
Crypto Asset, Number of Units, Total
Digital assets, Units
Research and Development Arrangement, Contract to Perform for Others, Type [Domain]
Debt Instrument, Interest Rate, Effective Percentage
Default Rate
Entity Address, Address Line One
Entity Address, Address Line One
Schedule of Stock Options Valuation Assumption Used
Assumptions Used in the Black-Scholes Option-Pricing Method Related To Options Issued to Employees and Nonemployees
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Representative Warrants Outstanding[Member]
Representative Warrants Outstanding
Representative Warrants Outstanding [Member]
Fair Value Hierarchy and NAV [Axis]
Non-cash interest expense for deferred consideration
Other Noncash Expense
Earnings Per Share [Abstract]
Net loss per share attributable to common stockholders - basic and diluted
Ordinary shares subject to possible redemption 13,800,000 as of December 31, 2021 and no shares as of December 31, 2020 at redemption value of $10.10
Ordinary Shares Subject to Possible Redemption
Temporary Equity, Carrying Amount, Attributable to Parent
As Restated Member
As Restated [Member]
AsRestatedMember
Dividend of Dream Bowl Meme Coin I Tokens [Member]
Dividend of Dream Bowl Meme Coin I Tokens [Member]
Dividend of Dream Bowl Meme Coin I Tokens [Member]
Crpto Asset Coin Price
Crpto Asset Coin Price
Crpto Asset Coin Price
Goodwill and Intangible Assets
Goodwill and Intangible Assets Disclosure [Text Block]
Statement of Financial Position Location, Balance [Axis]
Investment Type [Axis]
Accrued research and development costs
Accrued research and development costs
Accrued research and development costs
Less Abstract
Less:
LessAbstract
Loan derivative liability
Loan derivative liability
Loan derivative liability
Additional ROU assets
Operating lease right-of-use asset
Operating Lease, Right-of-Use Asset
Acquired technology
Acquired technology [Member]
Acquired technology [Member]
Net Income (Loss) Attributable to Noncontrolling Interest
Net Income (Loss) Attributable to Noncontrolling Interest, Total
Net income for Scilex Bio attributable to the noncontrolling interest
Net income attributable to noncontrolling interests
Gain (Loss) on Sale of Investments
Gain (Loss) on Sale of Investments, Total
Realized (gain) loss on EMI
Class of Warrant or Right [Axis]
Business Combination, Recognized Asset Acquired, Other Asset, Current
Other current assets
Document Type
Document Type
Goodwill and Intangible Assets, Policy [Policy Text Block]
Goodwill and Other Long-Lived Assets
Company's ownership percentage
Organization Ownership Percentage
Organization Ownership Percentage
Gross Profit
Gross Profit, Total
Gross Revenue
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Sorrento Therapeutics, Inc. [Member]
Sorrento Therapeutics, Inc. [Member]
Sorrento Therapeutics, Inc. [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Entity Central Index Key
Entity Central Index Key
Effect of dilutive securities
Effect of Dilutive Securities
Effect of Dilutive Securities
Deposit Warrant Exercise Price
Deposit Warrant Exercise Price
Warrant Exercise Price
Aggregate Amount Payable Under License Agreements
Aggregate amount payable under license agreements.
Aggregate amount payable under license agreements
Foreign Currency Transaction Loss, before Tax
Loss on exchange transaction
Shares issued under December Registered Direct Offering, Shares
Shares issued under December Registered Direct Offering, Shares
Shares issued under December 2024 RDO, Shares
Payments To Settle Financing Arrangements Noncurrent
Payments To Settle Financing Arrangements Noncurrent
Payments to settle financing arrangements, noncurrent
Valuation Approach and Technique [Axis]
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Net change in cash and cash equivalents
Subsequent Event Type [Domain]
Fair Value of the Fee Warrant
Fair Value Adjustment of Warrants
Fair value of warrants
StockBlock Warrants [Member]
StockBlock Warrants [Member]
StockBlock Warrants [Members]
ConvertibleDebentureprincipalAmount
ConvertibleDebentureprincipalAmount
Convertible Debenture principal Amount
Business Combination, Consideration Transferred, Tangible and Intangible Assets, Excluding Cash
Cash consideration
Schedule of condensed balance sheets
Condensed Balance Sheet [Table Text Block]
Percentage of Usage of Cash Proceeds from Cash Sweep Financing
Percentage of Usage of Cash Proceeds from Cash Sweep Financing
Percentage of usage of cash proceeds from cash sweep financing
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Transfer of Common Stock Shares
Transfer of Common Stock Shares
Transfer of Common Stock Shares
Call option value
Call option value
Call option value
Fair value per share of common stock on date of grant
Common stock, par value
Common Stock, Par or Stated Value Per Share
Aggregate net sales for the licensed product
Aggregate Net Sales For The Licensed Product
Aggregate Net Sales For The Licensed Product
Operating and formation costs
Operating Costs and Expenses
Total net operating costs and expenses
Proceeds from Issuance of Warrants
Proceeds from issuance of warrants
Proceeds from issuance of shares under direct offerings
EOS Technology Holdings Patent Agreement [Member]
EOS Technology Holdings Patent Agreement Member
EOS Technology Holdings Patent Agreement [Member]
Tranche One
Share-Based Payment Arrangement, Tranche One [Member]
Liabilities:
Liabilities [Abstract]
Amount due for New Drug Application
Amount due for New Drug Application
Amount due for New Drug Application
Noncontrolling Interest, Increase from Subsidiary Equity Issuance
7.0% noncontrolling interest in VHC subsidiaries
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Outstanding, Weighted-average Remaining Contractual Life, (in Years)
Issuance of Firm Warrants as part of the Bought Deal Offering, RDO Common Warrants as part of the Registered Deal Offering and Deposit Warrants as part of the Commitment Letter
Issuance of Firm Warrants and Representative Warrants as part of the Bought Deal Offering
Issuance of Firm Warrants and Representative Warrants as part of the Bought Deal Offering
Issuance of Firm Warrants as part of the Bought Deal Offering, RDO Common Warrants as part of the Registered Direct Offering and Private Warrants as part of Oramed Side Letter
Scilex Bio JV [Member]
Scilex Bio JV [Member]
Scilex Bio JV [Member]
Parent [Member]
Subsequent Penny Warrants 3 [Member]
Subsequent Penny Warrants 3 [Member]
Subsequent Penny Warrants 3 [Member]
Combined Price Paid Of Warrant
Combined Price Paid Of Warrant
Combined Price Paid
Options Outstanding, Exercised
Options Outstanding, Exercised
Options Outstanding, Exercised
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Stock options exercised (in shares)
Other Prepaid Expense, Current
Prepaid expenses and other current assets
Debt Disclosure [Abstract]
Long-Term Debt, Transaction [Axis]
Long-Term Debt, Transaction [Axis]
Cash fee percentage of gross proceeds paid to placement agents
Cash Fee Percentage of Gross Proceeds Paid to Placement Agents
Cash Fee Percentage of Gross Proceeds Paid to Placement Agents
Payment for Acquisition, Lease, Held-for-Investment
Payment made for PA OPS investment
Valuation Technique, Black-Scholes-Merton Model [Member]
Black Scholes Model
Payment Upon The Achievement of Net Sales
Payment upon the achievement of net sales
Payment upon the achievement of net sales
Upfront Cash Contribution
Upfront Cash Contribution
Upfront Cash Contribution
Purchase Price Per Share
Purchase price per unit (in Dollars per share)
PurchasePricePerShare
Accrued purchases
Accrued purchases
Accrued purchases
License fee payable
License Fee Payable
License Fee Payable
Marketable Securities
Marketable Securities, Total
Marketable securities
Purchase Of Preferred Shares
Purchase Of Preferred Shares
Purchase of preferred shares
Accrued Liabilities, Current
Total accrued rebates and other sales-related accruals
Accrued Expenses
Current Fiscal Year End Date
Current Fiscal Year End Date
Datavault Common Stock [Member]
Datavault Common Stock [Member]
Datavault Common Stock [Member]
Schedule of Long-Term Debt Instruments [Table]
Liquidity and Going Concern [Line Items]
Liquidity and Going Concern [Line Items]
Adjustments Restatement2 Member
Adjustments Restatement 2 [Member]
AdjustmentsRestatement2Member
Document Quarterly Report
Other long-term assets
Business Combination, Recognized Asset Acquired, Other Asset, Noncurrent
Option Agreement [Member]
Option Agreement [Member]
Option Agreement [Member]
FounderShares
Founder shares (in Shares)
Number of founder shares.
Accounts Payable, Other
Accounts Payable
Schedule Of The Calculation Of Basic And Diluted Net Income Per Ordinary Share Abstract
Schedule of the calculation of basic and diluted net income per ordinary share [Abstract]
Fair Value, by Balance Sheet Grouping [Table]
Entity Address, State or Province
Gain from Kind Dividend
Gain from Kind Dividend
Gain from property in kind dividend
Gain from property in kind dividend
Stock Issued During Period, Value, Conversion of Convertible Securities
Number of shares exchange, value
Aggregate Purchase Price Of Share
Aggregate Purchase Price Of Share
Aggregate purchase price
Investment Agreement
Investment Agreement [Member]
Investment Agreement [Member]
Investment Agreement [Member]
Debt Payable [Axis]
Debt Payable [Axis]
Payment for Contingent Consideration Liability, Operating Activities
Cash payment for discharge of Indebtedness Agreement
Investment, Name [Domain]
Preferred Stock, Shares Outstanding, Ending Balance
Preferred Stock, Shares Outstanding, Beginning Balance
Preferred stock, shares outstanding
Preference shares outstanding
Preferred Stock, Shares Outstanding
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive loss attributable to common stockholders
Comprehensive loss attributable to common stockholders
Public Offering Price Combined
Public Offering Price Combined
Public Offering Price Combined
Warrant Transfer Agreement [Member]
Warrant Transfer Agreement [Member]
Warrant Transfer Agreement
Common stock shares reserved for future issuance
Common Stock, Capital Shares Reserved for Future Issuance
Aggregate shares purchase common warrants
(Gain) Loss on Compound Derivative of St. James-Scilex Loans
(Gain) Loss on Compound Derivative of St. James-Scilex Loans
Loss on compound derivative of Scilex-St. James Loans
Loss on compound derivative of Scilex-St. James Loans
Weighted average common stock warrants exercisable for nominal consideration
Weighted Average Common Stock Warrants Exercisable, Nominal Consideration
Weighted average common stock warrants exercisable for nominal consideration
Class of Warrant or Right [Domain]
Proceeds From After Transaction Fees Paid
Proceeds From After Transaction Fees Paid
Proceeds From After Transaction Fees Paid
Purchased Revenue Liability
Contract with Customer, Liability, Revenue Recognized
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions, Total
Unrealized (gain) on equity method investments carried at fair value, net
Unrealized loss on equity method investments carried at fair value, net
Partner Capital Components [Domain]
Mr. Mack [Member]
Mr. Mack [Member]
Liquidity and Going Concern [Table]
Liquidity and Going Concern [Table]
Conversion of Shares
Conversion of Stock, Shares Converted
Series A Financing
Series A Financing [Member]
Series A Financing [Member]
Accounts Receivable [Member]
Schedule of FSF Deposit
Summary Of The Changes In The Balance And The Estimated Fair Value Of The FSF Deposit
Summary of the Changes in the Balance and the Estimated Fair Value of the FSF Deposit
Noncontrolling interests
Equity, Attributable to Noncontrolling Interest
Equity, Attributable to Noncontrolling Interest, Ending Balance
Equity, Attributable to Noncontrolling Interest, Beginning Balance
Equity, Attributable to Noncontrolling Interest, Total
Noncontrolling interests
Noncontrolling interests
Crypto Asset, Other [Member]
Digital Assets [Member]
Debt Payable [Domain]
Debt Payable [Domain]
Payments for Royalties
Payments for royalties
Accrued Exchange Fee Rebate
Rebate Balance
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]
Holding Period
Holding period
HoldingPeriod
Descriptionof Organizationand Business Operations Details Line Items
Description of Organization and Business Operations (Details) [Line Items]
Stock Issued During Period, Value, Stock Options Exercised
Stock options exercised
Outstanding balance of revolving facility
Outstanding balance of revolving facility
Outstanding balance of revolving facility
Initial Upfront Payment Due Under The Licensing Arrangement Recognised As Current Liability
Initial upfront payment due under the licensing arrangement recognised as current liability.
Initial upfront payment due under the licensing arrangement recognised as current liability
Ordinary per share
Preferred Stock, Redemption Price Per Share
Schedule of Deferred Tax Liabilities and Related Valuation Allowance
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
Stock Options [Member]
Equity Option [Member]
ACEA Hangzhou Agilent Bio Loan Agreement [Member]
ACEA Hangzhou Agilent Bio Loan Agreement [Member]
ACEA Hangzhou Agilent Bio Loan Agreement
Non-cash operating lease cost
Non Cash Operating Lease Cost
Non cash operating lease cost.
Liquidated damages
Loss Contingency Accrual, Product Liability, Gross, Total
Loss Contingency Accrual, Product Liability, Gross
Proceeds from Sale and Maturity of Marketable Securities
Sale of Marketable Securities
Subsequent Event [Member]
Subsequent Event [Member]
Property, Plant and Equipment [Abstract]
Deferred Revenue Arrangement Type [Axis]
Debt Instrument, Unused Borrowing Capacity, Fee
Financing Fees
Scilex-St. James Loan Agreement And Amendment [Member]
Scilex-St. James Loan Agreement And Amendment [Member]
Scilex-St. James Loan Agreement and Amendment
Antidilutive Securities [Axis]
Business Combination, Recognized Asset Acquired, Prepaid Expense and Other Asset, Current
Prepaid expenses
Proceed s of sale of common shares percentage
Proceed's of sale of common shares
Proceed's of sale of common shares percentage
Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]
Supplemental disclosure:
Issuance of common stock upon warrants exercise, shares
Issuance of Common Stock Upon Warrants Exercise, Shares
Issuance of Common Stock Upon Warrants Exercise, Shares
Basis of Presentation and Significant Accounting Policies [Text Block]
Basis of Presentation and Principles of Consolidation
Interest Expense, Debt
Interest Expense, Debt, Total
Interest Expense for debt
Outstanding Equity Percent
Outstanding Equity Percent
Outstanding equity
Debt Instrument, Unamortized Discount
Debt Instrument, Unamortized Discount, Total
Unamortized discount
Related Party Transaction [Axis]
AOCI Attributable to Parent [Member]
Accumulated Other Comprehensive Income [Member]
Customer [Domain]
Derivative liabilities
Fair value, ending
Fair value, beginning
Derivative Liability, Total
Warrant Liability
Derivative Liability
Finite-Lived Intangible Assets, Major Class Name [Domain]
Cash [Member]
Cash [Member]
Compensatory Damages
Compensatory Damages
Compensatory damages
Treasury Stock, Common, Shares
Treasury Stock Common Shares Outstanding
Treasury stock share
Treasury Stock, Beginning Balance (in shares)
Treasury Stock, Ending Balance (in shares)
Total Number Of Shares Granted
Total Number of Shares Granted
Total number of shares granted
Right to Sell Maximum Number of Common Stock Shares
Right to Sell Maximum Number of Common Stock Shares
Right to sell maximum number of common stock shares
Milestone Payment
Milestone Payment
Schedule of revenue liability activity
Schedule of Revenue Liability Activity [Table Text Block]
Schedule of Revenue Liability Activity [Table Text Block]
Cash and Cash Equivalents [Domain]
Agreement maturity date
Agreement Maturity Date
Agreement Maturity Date
Semnur 2024 Stock Option Plan [Member]
Semnur 2024 Stock Option Plan [Member]
Semnur 2024 Stock Option Plan
Long Term Debt Transactions [Domain]
Long Term Debt Transactions Domain
Percentage of estimated fair value expensed as in-process research and development
Percentage of Estimated Fair Value Expensed As In-Process Research And Development
Percentage of estimated fair value expensed as in-process research and development.
Business Combination, Consideration Transferred
Business Combination, Consideration Transferred, Total
Cash consideration paid
Total purchase consideration
Romeg License Agreement [Member]
Romeg License Agreement [Member]
Stock Purchase Agreement [Member]
Stock Purchase Agreement [Member]
Sorrento Stock Purchase Agreement [Member]
Preferred Stock, Value, Issued
Preferred Stock, Value
Aggregate purchase price of share
Business Combination, Consideration Transferred, Equity Interest, Share Issued, Value
Intangible asset
Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Excluding Goodwill
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total
Payment for Debt Extinguishment or Debt Prepayment Cost
Prepayment costs
Extended payments
Selling, general and administrative
Selling, General and Administrative Expense
Selling, General and Administrative Expense, Total
Common stock upon conversation of cash
Asset Acquisition, Consideration Transferred, Contingent Consideration
Debt maturity date
Debt Instrument, Maturity Date
Maturity Date
Long-Term Debt, Transaction [Domain]
Long-Term Debt, Transaction [Domain]
Minimum [Member]
Minimum
Tranche B Note
Tranche B Note
Tranche B Notes
Ending Balance as of March 31, 2026
Ending Balance as of December 31, 2025
Financial Instrument [Axis]
Non-Refundable Deposit Amount
Non-Refundable Deposit Amount
Non-Refundable Deposit Amount
Current assets:
Assets, Current [Abstract]
Equity Method Investments [Table Text Block]
Summary of financial data for investments accounted for under the equity method of accounting
Net Income Attributable to Noncontrolling Interests
Net income attributable to noncontrolling interests.
Net income attributable to noncontrolling interests
Net loss attributable to noncontrolling interests
Amortization expense
Intangible amortization
Amortization of Intangible Assets
Level 3 [Member]
Fair Value, Inputs, Level 3 [Member]
Up-front license fee
UpFrontLicenseFee
UpFrontLicenseFee
Contingent Consideration Short-Term
Contingent Consideration Short-Term
Contingent consideration liability
Business Combination, Recognized Asset Acquired, Asset
Business Combination, Recognized Asset Acquired, Asset, Total
Total assets acquired
Payment for Purchased Asset
Business Combination [Policy Text Block]
Acquisitions
Unrealized Gain (Loss) on Investments
Unrealized loss on EMI
Preferred Stock, Dividends Per Share, Declared
Preferred Stock, Dividends Per Share, Declared
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
Schedule of fair value liabilities measured on a recurring basis
Current liabilities:
Liabilities, Current [Abstract]
November 2025 Placement Agent Warrants [Member]
November 2025 Placement Agent Warrants [Member]
November 2025 Placement Agent Warrants [Member]
Assets acquired:
Business Combination, Recognized Asset Acquired, Asset, Current [Abstract]
Related Party Transactions [Abstract]
No of Calendar Days
No of Calendar Days
No of Calendar Days
Issuance of Common Stock Under Bought Deal Offering Warrants Value
Issuance of Common Stock Under Bought Deal Offering Warrants Value
Issuance of Common Stock Under Bought Deal Offering Warrants Value
Purchased Revenue Liability [Member]
Purchased Revenue Liability
Purchased Revenue Liability
Payments for Repurchase of Warrants
Repurchase of warrants
Cash consideration paid in connection with warrant repurchase
Repurchase of warrants
Cash consideration paid in connection with the repurchase of Penny Warrants
Four Customer [Member]
Four Customer [Member]
Four Customer [Member]
Four Equal Installments [Member]
Four Equal Installments [Member]
Percent of total number of shares issued to agents in the Offering
Percent of Total Number of Shares Issued to Agents in the Offering
Percent of Total Number of Shares issued to Agents in the Offering
Shares, Outstanding
Begning Balance (in shares)
Ending Balance (in shares)
Accounts receivable, net
Accounts Receivable, after Allowance for Credit Loss, Current
Accounts Receivable, after Allowance for Credit Loss, Current, Total
Crypto Asset, Fair Value
Crypto Asset, Fair Value, Total
Digital assets, Fair Value
Beginning Bitcoin balance at fair value December 31, 2025
Ending balance at fair value March 31, 2026
Restricted cash
Restricted Cash and Cash Equivalent
Restricted Cash and Cash Equivalents, Total
Tranche B Warrants [Member]
Tranche B Warrants [Member]
Tranche B Warrants [Member]
Commitments and Contingencies
Commitments and contingencies (See Note 13)
Treasury Stock transferred to Tranche B Investors for Tranche B Note deferral
Treasury Stock transferred to Tranche B Investors for Tranche B Note deferral
Treasury Stock transferred to Tranche B Investors for Tranche B Notes deferral
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Total
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid
settlement claims
Total lease payments
Operating Lease, Liability
Total lease liabilities
Total lease liabilities
Total lease liabilities
Payments of Merger Related Costs, Financing Activities
Transaction costs paid related to Semnur Business Combination
Auditor Firm ID
Auditor Firm ID
Sale of Stock Percentage of Ownership after Transaction
Sale of Stock, Percentage of Ownership after Transaction
Federal Funds Purchased, Average Rate Paid
Federal funds purchased, average rate paid
Stockholders' Equity, Reverse Stock Split
Description of Stockholders' Equity, Reverse Stock Split
Forecast [Member]
Cash paid for amounts included in the measurement of lease liabilities:
Cash Flow, Operating Activities, Lessee [Abstract]
Accrued Marketing Costs, Current
Accrued sales and marketing costs
Prepaid expenses and other
Prepaid expenses and other
Increase (Decrease) in Prepaid Expenses, Other
Debt Exchange Agreement
Debt Exchange Agreement [Member]
Debt Exchange Agreement [Member]
Debt Instrument Principal Amount, Percentage
Debt Instrument Principal Amount, Percentage
Debt Instrument Principal Amount, Percentage
A&R Yorkville Purchase Agreement
A R Yorkville Purchase Agreement [Member]
A R Yorkville Purchase Agreement.
SPAC Warrants [Member]
SPAC Warrants [Member]
SPAC Warrants [Member]
Provision for Other Credit Losses
Allowance for Credit Losses
Concentration Risk Benchmark [Axis]
Percentage of aggregate net sales
Retail Land Sales Receivables, Stated Interest Rate
October 2024 Placement Agent Warrants [Member]
October 2024 Placement Agent Warrants [Member]
October 2024 Placement Agent Warrants
Legacy Scilex Stock Options [Member]
Legacy Scilex Stock Options [Member]
Legacy Scilex Stock Options [Member]
2027
Long-Term Debt, Maturity, Year Two
Accrued royalty payables
Royalty Guarantees, Commitments, Amount
Operating Expenses
Operating Expense [Member]
New Tranche B Notes [Member]
Senior Secured Convertible Notes [Member]
Senior Secured Convertible Notes [Member]
Senior Secured Convertible Notes [Member]
Common Stock Purchase Agreement [Member]
Common Stock Purchase Agreement [Member]
Common Stock Purchase Agreement [Member]
Long-term portion of deferred consideration
Long-term portion of deferred consideration
Long-term portion of deferred consideration
License Agreements Disclosure [Text Block]
License Agreements
License Agreements Disclosure [Text Block]
Interest Income (Expense), Operating
Interest Income (Expense), Operating, Total
Interest Income
Net income (loss)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Net loss
Net loss attributable to Scilex Holding, Inc.
Debt Instrument, Maturity Date Range, Start
Date of Maturity Start
Payment to Acquire License
Payment to Acquire License
Payment to acquire license
Cash and cash equivalents
Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Other Item
Other
Long-Term Debt, Type [Domain]
Weighted average number of shares - basic
Weighted average number of shares during the period-basic
Weighted Average Number of Shares Outstanding, Basic, Total
Weighted Average Number of Shares Outstanding, Basic
Allowances for Prompt Payment Discounts
Allowances for Prompt Payment Discounts
Allowances for prompt payment discounts
December Common Warrants Five Year [Member]
December Common Warrants Five Year
December Common Warrants Five Year [Member]
Scenario [Axis]
Stone Purchase Agreement [Member]
Stone Purchase Agreement [Member]
Stone Purchase Agreement
Treasury Stock paid for Gloperba Ex-U.S. License
Treasury Stock paid for Gloperba Ex-U.S. License
Treasury Stock paid for Gloperba Ex-U.S. License
FSF Loan [Member]
FSF Loan [Member]
F S F Loan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Aggregate Intrinsic Value, Exercisable
Schedule of Effective Income Tax Rate Reconciliation
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Payment made for Datavault Licenses
Payment for Licenses
Payment for Licenses
Tumim Purchase Agreement [Member]
Tumim Purchase Agreement [Member]
Tumim Purchase Agreement
Segments [Axis]
Warrant Repurchase Amount
Warrant Repurchase Amount
Warrant repurchase amount
Long-Lived Tangible Asset [Domain]
Interest Payable
Debt accrued interest
Subsequent Events [Text Block]
Subsequent Events
Total
Long-Term Debt
Related Party Transactions Disclosure [Text Block]
Related Party Transactions
Proposed Public Offering Abstract
Proposed Public Offering [Abstract]
Total Shareholders’ Equity (Deficit)
Equity, Attributable to Parent
Stockholders' Equity Beginning Balance
Stockholders' Equity Ending Balance
Total stockholders' deficit
Payments to Acquire Investments
Payments to Acquire Investments, Total
Payments to Acquire Investments
Preferred stock, par value
Preferred stock, par value
Preferred Stock, Par or Stated Value Per Share
Semnur Merger Agreement [Member]
Semnur Merger Agreement [Member]
Semnur Merger Agreement [Member]
Basis of Accounting, Policy [Policy Text Block]
Significant Accounting Policies
Purchase of Preferred Shares of Vivasor
Purchase of Preferred Shares of Vivasor
Purchase of preferred shares of Vivasor
Statement of Stockholders' Equity [Abstract]
Share-Based Payment Arrangement, Tranche Two [Member]
Tranche Two
Partner Capital Components [Axis]
Accrued expenses
Accrued expenses
Accrued expenses
Accrued expenses
Equity Method Investments
Equity Method Investments
Carrying value of the Company's investment
Excise tax paid in connection with share repurchase
Excise Tax Paid In Connection With Share Repurchase
Excise Tax Paid In Connection With Share Repurchase
Gain (Loss) on Securitization of Financial Assets
Realized loss on securities
February 2024 BDO Firm Warrants [Member]
February2024BDOFirmWarrants [Member]
February2024BDOFirmWarrants
Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
2025 (remainder of 2025)
Valuation Approach and Technique [Domain]
Series A Preferred Stock [Member]
Series A Preferred Stock [Member]
License Agreement [Member]
License Agreement [Member]
License Agreement
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
Loan Amount
Loan Amount
Loan
Business Combination, Recognized Asset Acquired, Property, Plant, and Equipment
Business Combination, Recognized Asset Acquired, Property, Plant, and Equipment, Total
Property, plant and equipment
Treasury Stock, Common [Member]
Treasury Stock [Member]
Long-Term Debt, Maturity, Year Five
2030
Leasehold improvements [Member]
Leaseholds and Leasehold Improvements [Member]
Defined Benefit Plan Disclosure [Line Items]
Tranche B Notes [Member]
Tranche B Notes [Member]
Tranche B Notes
Over-Allotment Option [Member]
Over-Allotment Option [Member]
Loss on foreign currency exchange
Gain (Loss), Foreign Currency Transaction, before Tax
Foreign Currency Transaction Gain (Loss), before Tax, Total
(Gain) Loss on foreign currency exchange
Upfront Fee Payable Under License Agreement Tranche One
Upfront fee payable under license agreement tranche one.
Upfront fee payable first tranche.
Entity Address, Address Line Two
Entity Address, Address Line Two
Fair Value Disclosures [Text Block]
Fair Value Measurements
Loan Agreement [Domain]
Loan Agreement [Domain]
Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Purchase Date
Purchase price of the common stock percentage
Warrant Exercise Agreement [Member]
Warrant Exercise Agreement [Member]
Warrant Exercise Agreement
Patent rights
Patent rights [Member]
Patent rights [Member]
Noncontrolling Interest [Member]
Non controlling Interest [Member]
Debt Instrument, Name [Domain]
Accrued Liabilities and Other Liabilities
Equity line of credit commitment shares liability
Accrued liability related to equity line of credit commitment shares
Scilex-St. James Loans [Member]
Scilex-St. James Loans [Member]
Scilex-St. James Loans [Member]
Summaryof Significant Accounting Policies Details Table
Summary of Significant Accounting Policies (Details) [Table]
Long-Term Debt, Maturity, Year Four
2029
Proposed Public Offering Text Block
PUBLIC OFFERING
ProposedPublicOfferingTextBlock
Schedule of Unrecognized Tax Benefits Roll Forward
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]
Debt Instrument, Periodic Payment
Debt Instrument, Periodic Payment, Total
Debt Instrument, Periodic Payment
Contingent Liability Reserve Estimate, Policy [Policy Text Block]
Contingent Consideration
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
Condensed Financial Information of Parent Company Only Disclosure [Text Block]
Plan Name [Domain]
Entity [Domain]
All Entities
Proceeds of Cryptocurrency
Proceeds of Cryptocurrency
Proceeds of Cryptocurrency
Credit Facility [Axis]
Equity Method Investment, Ownership Percentage
Ownership Equity Interest Rate
Schedule of impact of these adjustments to the financial statement, as previously reported
Condensed Financial Statements [Table Text Block]
Gross-to-net revenue Adjustment
Cost of Product and Service Sold
Gross-to-Net Revenue Adjustments Total
Gross-to-Net Revenue Adjustments Total
Purchased Revenue Liability
Purchased Revenue Liability [Policy Text Block]
Purchased Revenue Liability [Policy Text Block]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
Weighted-Average Exercise Price,Vested and expected to vest as of March 31, 2026
Private Warrants [Member]
Private Warrants [Member]
Private Warrants [Member]
Number Of Warrants Exercised
Number Of Warrants Exercised
Number Of Warrants Exercised
September Two Thousand Twenty-Five Warrants [Member]
September Two Thousand Twenty-Five Warrants [Member]
September 2025 Warrants [Member]
Warrants outstanding
Class of Warrant or Right, Outstanding
Treasury Stock, Value, Total
Treasury Stock, Value
Treasury stock, at cost; 60,068,585 shares as of each of March 31, 2024 and December 31, 2023
Treasury stock, at cost; 1,458,263 shares as of March 31, 2026 and December 31, 2025
Business Combination, Recognized Liability Assumed, Liability [Abstract]
Liabilities assumed:
Finite-Lived Intangible Asset, Expected Amortization,after Year Four
Finite-Lived Intangible Asset, Expected Amortization,after Year Four
Thereafter
Negative working capital
Working Capital
Working Capital
Related and Nonrelated Parties [Axis]
St James Loans [Member]
St James Loans [Member]
St James Loans [Member]
Public Warrants Purchase Common Stock[Member]
Public Warrants Purchase Common Stock[Member]
Public Warrants Purchase Common Stock
Accrued tax payable
Taxes Payable
Taxes Payable, Total
Entity Address, City or Town
Entity Address, City or Town
Pre funded warrant per share
Pre Funded Warrant Per Share
Pre Funded Warrant Per Share
NeuroBioGen Company [Member]
NeuroBioGen Company [Member]
NeuroBioGen Company [Member]
Issuance of Common Stock Warrants Under Registered Direct Offering
Issuance of Common Stock Warrants Under Registered Direct Offering
Issuance of Common Stock Warrants Under Registered Direct Offering Warrants
Contingent consideration, liability
Business Combination, Contingent Consideration, Liability
Business Combination, Contingent Consideration, Liability, Total
Contingent Payment
Federal depository insurance coverage
Cash, FDIC Insured Amount
Three Customers [Member]
Three Customers [Member]
Three Customers [Member]
Long term Purchase Period
Long-Term Purchase Commitment, Period
Fair value of Shares Repurchased
Fair value of Shares Repurchased
Fair Value of stock repurchased
Number of Reportable Segments
Security Exchange Name
Security Exchange Name
Credit Facility [Domain]
Repayment of Oramed Note
Repayment of Convertible Debentures
Repayment of Convertible Debentures
Repayment of Convertible Debentures
Property and equipment, gross
Property and equipment, gross
Property, Plant and Equipment, Gross
Property, Plant and Equipment, Gross, Ending Balance
Property, Plant and Equipment, Gross, Beginning Balance
Deposit Warrants [Member]
Deposit Warrants [Member]
Deposit Warrants [Member]
Developers [Member]
Developers [Member]
Developers [Member]
Investor Share Purchase Commitment
Investor Share Purchase Commitment
Investor agreed to purchase Share
Debt, Weighted Average Interest Rate
Debt Weighted Average Interest Rate
Oramed Letter Agreement [Member]
Oramed Letter Agreement [Member]
Oramed Letter Agreement
Sponsor Note [Member]
Sponsor Note [Member]
Sponsor Note
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Loss before income taxes
Loss before income taxes
Loss before income taxes
Interest Expense, Borrowings
Interest Expense, Borrowings, Total
Interest expense on borrowings
Concentration Risk Type [Domain]
April 2024 RDO Common Warrants [Member]
April 2024 RDO Common Warrants
April 2024 RDO Common Warrants [Member]
Shares issuable under the SIPA [Member]
Shares issuable under the SIPA
Purchase of patent
Purchase of Patent
Purchase of Patent
Second Closing [Member]
Second Closing [Member]
Second Closing [Member]
Antidilutive Securities, Name [Domain]
Epoladerm [Member]
Epoladerm Member
Epoladerm [Member]
Stock Option, Exercise Price, Decrease
Common stock exercise price
Stockholders' Equity Note [Abstract]
Schedule Of Impact Of These Adjustments To The Financial Statement As Previously Reported Abstract
Schedule of impact of these adjustments to the financial statement, as previously reported [Abstract]
Inventory
Inventory, Net
Inventory, Net, Total
Shares issuable under Tranche B Notes [Member]
Shares issuable under Tranche B Notes [Member]
Shares issuable under Tranche B Notes
Total cash, cash equivalents, and restricted cash
Restricted cash
Cash and cash equivalents at end of period
Cash and cash equivalents at beginning of period
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Statistical Measurement [Domain]
Private Placement Disclosure Textblock Abstract
Private Placement Disclosure Textblock [Abstract]
Exercise price per share, warrants
Class of Warrant or Right, Exercise Price of Warrants or Rights
Warrants exercised price
Total current assets:
Assets, Current
Total current assets
Document Period End Date
Document Period End Date
Accrued Interests
Accrued Interests
Accrued interest
Title and Position [Axis]
Fair Value Hierarchy and NAV [Domain]
ICFR Auditor Attestation Flag
ICFR Auditor Attestation Flag
Remaining Drawable Balance [Member]
Remaining Drawable Balance [Member]
Remaining Drawable Balance [Member]
Business Combination, Contingent Consideration, Asset
Business Combination, Contingent Consideration, Asset, Total
Business Acquisition
Percentage on net sale
Royalty Payment Percentage On Net Sale
Royalty Payment Percentage On Net Sale
Options Outstanding, Exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Number of shares exercisable
Weighted average period over grant
Weighted average period over grant
Weighted average period over grant
Weighted average number of shares outstanding
Weighted Average Number of Shares Outstanding
Weighted Average Number of Shares Outstanding
ZTlido Royalty [Member]
ZTlido Royalty [Member]
ZTlido Royalty [Member]
Accrued payroll
Accrued Salaries, Current
Research and Development Facilities [Member]
Research and Development Facilities [Member]
Research and Development Facilities [Member]
Reduction in additional paid-in capital
Adjustments to Additional Paid in Capital, Fair Value
Weighted average remaining life for identifiable intangible assets
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life
Statement of Financial Position [Abstract]
Stock Issued During Period, Shares, Purchase of Assets
Number of shares purchase
Three I Fund Agreement [Member]
Three I Fund Agreement [Member]
Three I Fund Agreement [Member]
Revenue [Policy Text Block]
Revenue Recognition
Equity Unit Purchase Agreements [Member]
Securities Purchase Agreement with Yorkville (Member)
Equity Purchase Agreement with Yorkville and B. Riley [Member]
Realized (gain) loss on equity method investments, net
Realized (gain) loss on equity method investments, net
Realized (gain) on equity method investments carried at fair value, net
Realized (gain) on equity method investments carried at fair value, net
December RDO Common Warrants [Member]
December RDO Common Warrants [Member]
December RDO Common Warrants
Vesting [Axis]
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Other comprehensive income:
Class of Stock [Axis]
Compensation and Employee Benefit Plans [Text Block]
Stock Incentive and Employee Benefit Plan
Deferral Fee
Deferral Fee
Deferral fee
In Process Research and Development, Policy [Policy Text Block]
Valuation of Purchased In-Process Research and Development, Goodwill, and Other Intangible Assets
Legacy Common Stock [Member]
Legacy Common Stock [Member]
Legacy Common Stock [Member]
Biconomy PTE Ltd [Member]
Biconomy PTE Ltd [Member]
Change in fair value of FSF Deposit
Increase (Decrease) in Deposits
Increase (Decrease) in Deposits, Total
Total liabilities
Total Liabilities
Liabilities
Former Employee [Member]
Former Employee [Member]
Placement Agent Warrants [Member]
Placement Agent Warrants [Member]
Placement Agent Warrants
April 2024 RDO Placement Agent Warrants [Member]
Aggregate Gross Proceeds From Offering
Aggregate Gross Proceeds From Offering
Gross proceeds from offering
Ordinary shares issuance costs
The cash inflow from the additional capital contribution to the entity.
OrdinarySharesIssuanceCost
Financial Instruments [Domain]
Datavault Meme Coin and Warrant Distributions [Member]
Datavault Meme Coin and Warrant Distributions [Member]
Percentage of net revenue, sole distributor
Percentage of net revenue, sole distributors
Percentage of net revenue, sole distributors
Preferred Stock Dividend Shares
Preferred Stock Dividend Shares
Preferred stock dividend shares
Company receives the Deposit
Company Receives The Deposit Amount
Company Receives The Deposit Amount
Number of common shares authorized for issuance
Number of Common Shares Authorized for Issuance
Number of Common Shares Authorized for Issuance
License Agreement, Description
License Agreement Description
License Agreement Description
Other Vivasor Borrowings [Member]
Other Vivasor Borrowings [Member]
Other Vivasor Borrowings
Business Combination [Member]
Business Combination [Member]
Business Combination [Member]
Derivative Liability, Statement of Financial Position [Extensible Enumeration]
Lessee, Operating Lease, Liability, to be Paid, Year Two
2028
Indefinite-Lived Intangible Assets, Major Class Name [Domain]
Long-Term Debt, Description
Debt contractual terms
Gross carrying amount
Finite-Lived Intangible Assets, Gross
Finite-Lived Intangible Assets, Gross, Total
Employee Stock Purchase Plan [Member]
Employee Stock Purchase Plan [Member]
Employee Stock Purchase Plan [Member]
Note discount rate
Secured Note Discount Rate
Secured Note Discount Rate
Weighted average number of shares, diluted
Weighted average number of shares during the period -diluted
Weighted Average Number of Shares Outstanding, Diluted, Total
Weighted Average Number of Shares Outstanding, Diluted
Entity File Number
Securities Act File Number
Cover [Abstract]
Cover
Business Combination Consideration Transferred Cash
Business Combination Consideration Transferred Cash
Cash consideration
Accrued expenses
Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total
Increase (Decrease) in Accounts Payable and Accrued Liabilities
Initial Closing [Member]
Initial Closing [Member]
Initial Closing [Member]
EAR SPV [Member]
EAR SPV [Member]
Other current liabilities
Business Combination, Recognized Liability Assumed, Other Liability, Current
Investments [Domain]
Loss on derivative liability
Loss on derivative liability
Derivative, Gain (Loss) on Derivative, Net
Derivative, Gain (Loss) on Derivative, Net, Total
Gain on derivative liability
Gain on warrant derivative liabilities
Noncontrolling Interest, Increase from Sale of Parent Equity Interest
69.2% noncontrolling interest in VHC
Other Long-Term Debt, Noncurrent
Debt, net of issuance costs
Legacy Scilex Common Stock [Member]
Legacy Scilex Common Stock [Member]
Legacy Scilex Common Stock [Member]
Chargebacks [Member]
Chargebacks [Member]
Chargebacks [Member]
Revenue Benchmark [Member]
Scenario [Domain]
Crypto Asset, Holding [Table]
Long-Term Debt, Maturities, Repayment Terms
Loan agreement repayment terms
Sale of Stock [Domain]
Bitcoin [Member]
Bitcoin [Member]
Bitcoin
Pre-funded warrants to purchase
Pre Funded Warrants to Purchase
Pre Funded Warrants to Purchase
Retainer shares issued
Retainer shares issued
Retainer shares issued
Sales rebates [Member]
Sales Rebates [Member]
Sales Rebates [Member]
Reduction of the Principal Balance
Reduction of the Principal Balance
Reduction of the principal balance
Number of shares acquired
Stock Issued During Period, Shares, Acquisitions
Commitment Shares to be Paid
Digital Assets
Digital Assets
Digital assets
Options Outstanding, Forfeited/Cancelled
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total
Number of shares common stock forfeited
Subsequent Event [Table]
Accounts payable
Business Combination, Recognized Liability Assumed, Accounts Payable, Current
Earnings Per Share, Diluted, by Common Class, Including Two-Class Method [Table]
Expiration date
Share Repurchase Program, Expiration Date
Short-Term Debt, Type [Domain]
Total
Intangibles, net
Finite-Lived Intangible Assets, Net
Finite-Lived Intangible Assets, Net, Ending Balance
Finite-Lived Intangible Assets, Net, Beginning Balance
Debt Instrument, Convertible, Conversion Price
Conversion Price
Common stock at a conversion price
Operating Lease, Expense
Lease Expense
Definitive Agreement [Member]
Definitive Agreement [Member]
Definitive Agreement [Member]
SCLX JV-St. James Loan Agreement [Member]
SCLX JV-St. James Loan Agreement [Member]
SCLX JV-St. James Loan Agreement
Other long-term liabilities
Other long-term liabilities
Other long-term liabilities
Ordinary shares subject to possible redemption
Ordinary shares subject to possible redemption.
SharesSubjectToPossibleRedemption
Property, Plant and Equipment, Useful Life
Property Plant And Equipment Useful Life
Transaction costs paid in connection with share repurchase
Transaction costs paid in connection with share repurchase
Transaction costs paid in connection with share repurchase
Transaction costs paid in connection with share repurchase
Short-Term Debt, Type [Axis]
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Pronouncements
Schedule of Lease Maturities of Lease Liabilities
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]
Stock Issued During Period, Shares, Conversion of Convertible Securities
Number of shares exchange
Business Combination, Recognized Liability Assumed, Liability
Total liabilities assumed
Stock Issuance Agreement [Member]
Stock Issuance Agreement [Member]
Stock Issuance Agreement
Private Placement Details Line Items
Private Placement (Details) [Line Items]
Purchase Agreement [Axis]
Purchase Agreement Axis
SPAC Transaction [Member]
SPAC Transaction [Member]
Depreciation expense
Depreciation
Depreciation, Total
Operating lease, lease term
Lessee, Operating Lease, Term of Contract
Common stock, shares outstanding
Common Stock, Shares, Outstanding, Ending Balance
Common Stock, Shares, Outstanding, Beginning Balance
Common Stock, Shares, Outstanding
Agreed to purchase Common Stock
Less current portion of lease liability
Current portion of operating lease liabilities
Operating Lease, Liability, Current
Subsequent Penny Warrants [Member]
Subsequent Penny Warrants [Member]
Subsequent Penny Warrants [Member]
Related Party Loans
Related Party Loans
Related Party Loans
Option Payment Amount
Option Payment Amount
Option payment amount
Long-Term Debt, Average Amount Outstanding
Average outstanding debt
Depreciation and amortization
Depreciation, Depletion and Amortization
Depreciation, Depletion and Amortization, Total
Schedule of aggregate principal amount of our long-term debt maturing
Contractual Obligation, Fiscal Year Maturity [Table Text Block]
Document Transition Report
Document Transition Report
Research and development
Research and Development Expense
Research and Development Expense, Total
Accrued research and development costs
Laura Hamill [Member]
Laura Hamill [Member]
Laura Hamill [Member]
Asset Impairment Charges
Asset Impairment Charges, Total
Impairment Loss
Cost of revenue
Cost of Revenue
Cost of Revenue, Total
Revenue recognized
October Common Warrants [Member]
October Common Warrants [Member]
October 2024 Noteholder Warrants
Summaryof Significant Accounting Policies Details Line Items
Summary of Significant Accounting Policies (Details) [Line Items]
Schedule of Components of Benefit for Income Taxes
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
Statement of Cash Flows [Abstract]
Implementation fee of Second And Third Year
Implementation fee of Second And Third Year
Implementation fee of Second And Third Year
Vivasor Secondary Stock Purchase [Member]
Vivasor Secondary Stock Purchase [Member]
Datavault Meme Coin [Member]
Datavault Meme Coin [Member]
Datavault Meme Coin [Member]
Common stock issuable under Sponsor Interest Purchase Agreement
Common stock issuable under Sponsor Interest Purchase Agreement
Common stock issuable under Sponsor Interest Purchase Agreement
Underlying warrant value
Underlying warrant value
UnderlyingWarrantValue
Cost, Amortization
Amortization payment
Issued stock
Stock Issued During Period, Value, New Issues
Schedule of Stock Options Outstanding Activity
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Fair Value, Option, Changes in Fair Value, Gain (Loss)
Loss in changes in fair value
Loss in changes in fair value
Equity [Text Block]
Stockholders' Deficit
Number of Shares Selling
Number of Shares Selling
Frist Installment [Member]
Frist Installment [Member]
First installment [Member]
Finite-Lived Intangible Assets [Line Items]
Net Loss Per Share
Earnings Per Share [Text Block]
Historical carrying value of semnur shares
Historical Carrying Value Of Shares
Historical carrying value of shares
Value Of Stock Sold For Termination
Value Of Stock Sold For Termination Of Offering
Value Of Stock Sold For Termination Of Offering
Computer Equipment [Member]
Computers and equipment [Member]
Sale of Stock, Consideration Received Per Transaction
Fair value of common shares
Net loss
Net loss
Loan Agreement [Axis]
Loan Agreement [Axis]
Aggregate Intrinsic Value, Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Long Term Commitment Amount
Long-Term Purchase Commitment, Amount
Extended Loan
Realized (Gain) Loss on Digital Assets
Realized (Gain) Loss on Digital Assets
Unrealized loss on digital assets
Unrealized loss on digital assets
Inventory
Inventory
Increase (Decrease) in Inventories
Increase (Decrease) in Inventories, Total
Payments To Settle Financing Arrangements
Payments To Settle Financing Arrangements
Payments to settle financing arrangements
Principal laon amount
Principal laon amount
Principal loan amount
Product Development Agreement [Member]
Product Development Agreement [Member]
Product Development Agreement [Member]
Selling of Shares for Bitcoin to Biconomy
Selling of Shares for Bitcoin to Biconomy
Selling of Shares for Bitcoin to Biconomy
Tumim [Member]
Tumim [Member]
Tumim [Member]
Operating lease cost*
Operating Lease, Cost
Issuance of convertible note receivable for Qscan
Issuance of Convertible Note Receivable
Issuance of Convertible Note Receivable
Net cash used in operating activities
Cash Provided by (Used in) Operating Activity, Continuing Operation
Net Cash Provided by (Used in) Operating Activities, Continuing Operations, Total
Expected dividend yield
Dividend yield
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Intangibles, net
Intangible Assets, Net (Excluding Goodwill)
Intangible Assets, Net (Excluding Goodwill), Total
Derivative Instruments Gain Loss Recognized in Income Net
Derivative Instruments Gain Loss Recognized in Income Net
Loss on compound derivative of Scilex-St. James Loans
Operating cash flows from operating leases
Operating Lease, Payments
Operating cash flows from operating leases (in thousands)
Allowances for expected credit losses
Provision for Loan, Lease, and Other Losses
Provision for Loan, Lease, and Other Losses, Total
Financing Costs and Allocated Expense for Financial Instruments at Fair Value
Financing Costs and Allocated Expense for Financial Instruments at Fair Value
Financing costs and allocated expense for financial instruments at fair value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
Aggregate Intrinsic Value ,Vested and expected to vest as of March 31, 2026
Liquidity and Going Concern
Substantial Doubt about Going Concern [Text Block]
ASSETS
Assets:
Assets [Abstract]
Shah Agreement [Member]
Shah Agreement [Member]
Shah Agreement [Member]
Number of sale units
Number of Sale units.
NumberOfSaleUnits
Assembled workforce
Assembled workforce [Member]
Assembled workforce [Member]
Risk-free interest rate
Risk-free rate
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
February Two Thousand Twenty Six Warrants [Member]
February Two Thousand Twenty Six Warrants [Member]
February 2026 Warrants [Member]
Construction in progress [Member]
Construction in Progress [Member]
Repayment of Oramed Note
Repayments of Debt
Repayment of debt prinnciple installment
Repayment of Tranche B Note
Amortization of debt issuance costs and debt discount
Amortization of Debt Issuance Costs and Discounts
Amortization of Debt Issuance Costs and Discounts, Total
Aisen Biological
Aisen Biological [Member]
Aisen Biological Member
Public Warrants [Member]
Public Warrants [Member]
Public Warrants [Member]
Concentration Risk Threshold Percentage
Concentration Risk Threshold Percentage
Concentration risk percentage
Document Fiscal Year Focus
Document Fiscal Year Focus
Land and Building [Member]
Land and Building [Member]
Debt Instrument, Default Interest Rate
Debt Instrument, Default Interest Rate
Debt instrument, default interest rate
Acquired licenses
Acquired licenses [Member]
Acquired licenses [Member]
Concentration Risk Benchmark [Domain]
Investing activities
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
Royalty payment percentage related to future years
Royalty Payment Percentage Related To Future Years
Royalty Payment Percentage Related To Future Years
Accounts payable
Accounts Payable, Current
Accounts Payable, Current, Total
David Lemus Member
David Lemus Member
David Lemus [Member]
Debt Instrument, Owned, Percentage
Debt Instrument, Owned, Percentage
Debt instrument, owned, percentage
Shares Exchanged for Share
Shares Exchanged for Share
Shares Exchanged for Share
Interest Expense, Nonoperating, Total
Interest Expense, Nonoperating
Interest expense, net
Other expense, net
Equity Purchase Agreement [Member]
Equity Purchase Agreement [Member]
Equity Purchase Agreements
Exchange Warrants [Member]
Exchange Warrants [Member]
Exchange Warrants [Member]
ATM Sales Agreement [Member]
ATM Sales Agreement [Member]
ATM Sales Agreement
Increase (Decrease) in Other Noncurrent Assets
Other long-term assets
Purchased Revenue Liability Current
Purchased Revenue Liability Current
Purchased revenue liability, current
Purchased Revenue Liability
Non Refundable License Fee
Non Refundable License Fee
Non-refundable license fee
Service fees [Member]
Service fees [Member]
Service fees [Member]
Gain (loss) on investment in equity security measured at fair value
Equity Securities, FV-NI, Gain (Loss)
Equity Securities, FV-NI, Gain (Loss), Total
Percentage of Shares Issued and Outstanding
Percentage of Shares Issued and Outstanding
Percentage of number of common stock issued and outstanding
Warrant Purchase
Purchase Of Common Warrants
Purchase Of Common Warrants
Transaction Type [Axis]
Crypto Asset [Axis]
Estimated Fair Value Expensed As In-Process Research And Development Net
Estimated fair value expensed as in-process research and development net.
Estimated fair value expensed as in-process research and development net
Finite-Lived Intangible Asset, Expected Amortization, Year One
2026
Public Warrant [Member]
Public Warrant [Member]
Deposit Warrant Exercise Price
Exercise Price Of The Warrants
Exercise Price Of The Warrants
Datavault AI Coin [Member]
Datavault AI Coin [Member]
Datavault AI Coin [Member]
Shareholders Equity Details Table
Shareholders' Equity (Details) [Table]
Revision of Prior Period [Domain]
Prepayment Related To Q Scan Investment
Prepayment Related To Q Scan Investment
Upfront fee payable under license agreement
Upfront Fee Payable Under License Agreement
Upfront fee payable under license agreement.
Net Income Loss After Adjustments
Net income loss after adjustments.
Net loss attributable to Scilex Holding Company
Net loss attributable to noncontrolling interest
Liabilities Assumed
Liabilities Assumed
Issuance of Common Stock Warrants Under Registered Direct Offering Value
Issuance of Common Stock Warrants Under Registered Direct Offering Value
Issuance of Common Stock Warrants Under Registered Direct Offering Warrants Value
Convertible promissory notes
Convertible Debt
Convertible Debenture
Convertible Debt Issued And Sold
Ending Balance as of December 31, 2025
Ending Balance as of March 31, 2026
Vickers Debt Agreement [Member]
Vickers Debt Agreement [Member]
Vickers Debt Agreement [Member]
Gloperba Rest of World License Agreement [Member]
Gloperba Rest of World License Agreement [Member]
Gloperba Rest of World License Agreement [Member]
Schedule Of Derivative Component Of The Obligation Is Initially Valued And Classified As A Derivative Liability Abstract
Schedule of derivative component of the obligation is initially valued and classified as a derivative liability [Abstract]
Black-Scholes Option Pricing Method [Member]
Black-Scholes Option Pricing Method
Proceeds from issuance of St James Loan, net of issuance costs
Proceeds from Issuance of Scilex-St. James Loans
Proceeds from Issuance of Scilex-St. James Loans
Proceeds from issuance of St James Loan, net of issuance costs
Fair Value Disclosures [Abstract]
Commitments and Contingencies Disclosure [Abstract]
Purchase of convertible promissory note from Denali
Purchase of convertible promissory note
Purchase of convertible promissory note
Number of shares acquired, value
Stock Issued During Period, Value, Acquisitions
Exercise Price Of Common Warrant
Exercise Price Of Common Warrant
Exercise price of warrant
Lessee, Operating Lease, Liability, to be Paid, Year One
2027
Intangible Asset, Indefinite-Lived [Table]
Change in fair value of convertible debentures
Change In Fair Value Of Convertible Debentures Include Interest Expense
Change In Fair Value Of Convertible Debentures Include Interest Expense
Change in fair value of debt and liability instruments
Two Thousand Twenty Two Equity Incentive Plan [Member]
Two Thousand Twenty Two Equity Incentive Plan [Member]
2022 Equity Incentive Plan
Sale of Stock, Consideration Received on Transaction
Commitment Shares to be Paid
Net Income (Loss) Available to Common Stockholders, Basic
Net loss attributable to Scilex Holding, Inc.
Net loss for basic loss per share attributable to common stockholders
Net loss attributable to common stockholders
Deferred revenue
Business Combination, Recognized Liability Assumed, Deferred Revenue, Current
Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)
Total identifiable net liabilities
Shares issued under Registered Direct Offering, shares
Shares Issued During Period, Shares, Registered Direct Offering
Shares Issued During Period Registered Direct Offering
Monthly Basis [Member]
Monthly Basis [Member]
Monthly Basis [Member]
Debt Instrument [Axis]
Re-measurement of fair value
Re-measurement of fair value
fair value of the net assets acquired
Fair Value of Assets Acquired
Patent Rights Acquired Technology And Acquired Licenses [Member]
Patent Rights, Acquired Technology and Acquired Licenses [Member]
Patent Rights, Acquired Technology and Acquired Licenses [Member]
Share-Based Payment Arrangement [Abstract]
Purchased Revenue Liability Noncurrent
Purchased Revenue Liability Noncurrent
Purchased revenue liability, net of current portion
Deferred Revenue, Refund Payments
Payments on purchased revenue liability
Total assets measured at fair value
Assets, Fair Value Disclosure
Assets, Fair Value Disclosure, Total
Noncontrolling Interests [Policy Text Block]
Noncontrolling Interests [Policy Text Block]
Noncontrolling Interests
Sale of Stock [Axis]
Derivatives, Policy [Policy Text Block]
Derivative Liabilities
Settlement of Loans for Shares
Settlement of Loans for Shares
Settlement of St James Loans for Datavault shares
Commitments and Contingencies [Table]
Commitments and Contingencies [Table]
Deemed Dividended
Deemed Dividended
Deemed dividend
Derivative warrant liability private warrants
Derivative Warrant Liability Private Warrants
Derivative warrant liability private warrants.
Estimated fair value
Debt Instrument, Fair Value Disclosure
Debt Instrument, Fair Value Disclosure, Total
Net revenue
Revenues
Revenues, Total
Net cash used for investing activities
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Net Comprehensive Loss Attributable To Common Stockholders
Net Comprehensive Loss Attributable To Common Stockholders
Net comprehensive loss attributable to common stockholders
Net loss attributable to common stockholders
Private Placement Warrants [Member]
Private Placement [Member]
Private Placement [Member]
Title of 12(b) Security
Title of 12(b) Security
Loan agreement interest rate
Line of Credit Facility, Interest Rate at Period End
Shares Purchased At Par Value Under Stock Purchase Agreement
Shares Purchased At Par Value Under Stock Purchase Agreement
Shares Purchased At Par Value Under Stock Purchase Agreement
Condensed Financial Statements, Captions [Line Items]
Related and Nonrelated Parties [Domain]
Long-Term Debt, Maturity, after Year Five
Thereafter
Income Taxes
Income Tax Disclosure [Text Block]
Payments Of Debt
Payments Of Debt
Payments for Vivasor debt
Repayments on Promissory Note
Repayments on Promissory Note
Repayments on promissory note
Equity Method Investment, Aggregate Cost
Equity method investment, at fair value
Debt Instrument, Maturity Date Range, End
Maturity Date End
Changes In Disbursements and Counter Parties
Changes In Disbursements and Counter Parties
Disbursements and Counter Parties
Accrued litigation expenses
Accrued Liabilities, Fair Value Disclosure
Accrued Expenses
Patents [Member]
Patents
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
2026 (Remainder of 2026)
Number of Treasury Stock Paid For Gloperba Ex-US License Shares
Number of Treasury Stock Paid For Gloperba Ex-US License Shares
Treasury Stock paid for Gloperba Ex-U.S. License, Shares
Other long-term liabilities
Conversion Option Liability (see Note 5)
Other Liabilities, Noncurrent
Legal Entity [Axis]
Legal Entity:
Selling Expense
Implementation fee related to sales
Changes in operating assets and liabilities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Business Combination, Price Per Share
Price per share
Schedule of Property and equipment
Property, Plant and Equipment [Table Text Block]
Weighted Average Exercise Price, Outstanding, Ending Balance
Weighted Average Exercise Price, Outstanding, Beginning Balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Public Offering Price
Public Offering Price
Public Offering Price
Debt Repayment Exit Fee
Debt Repayment Exit Fee
Debt Repayment Exit Fee
Accrued legal fees
Accrued Professional Fees
Income Tax Disclosure [Abstract]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Promissory Notes
Promissory Notes
Promissory notes
Percentage of Lidocaine Topical System
Percentage of Lidocaine Topical System
Percentage of Lidocaine Topical System
Share Repurchase Program, Authorized, Amount
Number of share repurchase, value
Statement of Income Location, Balance [Axis]
Senior Notes [Member]
Senior Notes [Member]
Oramed Note [Member]
Ownership Interest Rate
Ownership Interest Rate
Ownership Interest Rate
Trading Symbol
Trading Symbol
Subsequent Penny Warrants 4 [Member]
Subsequent Penny Warrants 4 [Member]
Subsequent Penny Warrants 4 [Member]
Property, Plant and Equipment Disclosure [Text Block]
Balance Sheet Components
Debt Securities, Available-for-Sale, Purchased with Credit Deterioration, Discount (Premium)
Debt discounted fair value
Public Warrant And Private Placement Warrants [Policy Text Block]
Public Warrant And Private Placement Warrants [Policy Text Block]
Warrants
Royalty Purchase Agreement [Member]
Royalty Purchase Agreement [Member]
Royalty Purchase Agreement [Member]
Private Warrant liability acquired as part of the Business Combination
Private placement warrant liability acquired
Private placement warrant liability acquired
Condensed Financial Statements [Table]
Director
Director [Member]
Subsequent Event Type [Axis]
Adjustments Restatement 1 [Member]
Revision of Prior Period, Adjustment [Member]
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Financing activities
Term of options (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Term, in years
Crypto Asset, Unrealized Gain (Loss), Operating
Crypto Asset, Unrealized Gain (Loss), Operating, Total
Unrealized loss on digital assets
Entity Ex Transition Period
Entity Ex Transition Period
Total lease liabilities as of December 31, 2022
Total lease payments
Lessee, Operating Lease, Liability, to be Paid
Less imputed interest
Less imputed interest
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Equity Value
Equity Value
Equity Value
Company Receives The Deposit Period
Company Receives The Deposit Period
Company Receives The Deposit Period
Denominator Abstract0
Denominator:
DenominatorAbstract0
Goodwill impairment charges
Goodwill and Intangible Asset Impairment
Goodwill and Intangible Asset Impairment, Total
Consulting Fees
Consulting Fees
Consulting fees
Non Employee Director [Member]
Non Employee Director [Member]
Equity Components [Axis]
Schedule Of Net Gross Revenue
Schedule Of Net Gross Revenue [Table Text Block]
Schedule Of Net Gross Revenue [Table Text Block]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term
Weighted-Average Remaining Contractual Life, in year,Vested and expected to vest as of March 31, 2026
Research and Development Expense (Excluding Acquired in Process Cost)
In-process research and development expense
Finite-Lived Intangible Assets, Net, Amortization Expense, Rolling Maturity [Abstract]
As of March 31,2023
Nonoperating Income (Expense)
Total other (income) expense, net
Total other (income) expense, net
Cost of Revenue [Line Items]
Cost of Revenue [Line Items]
Conversion of Tranche B Notes into Common Stock, Shares
Conversion of Tranche B Notes into Common Stock, Shares
Conversion of Tranche B Notes into common stock, Shares
Equity Component [Domain]
Penny Warrants [Member]
Penny Warrants [Member]
Penny Warrants [Member]
Goodwill and Intangible Assets Disclosure [Abstract]
Third Installment [Member]
Third Installment [Member]
Third Installment [Member]
Datavault Pre-funded Warrant [Member]
Datavault Pre-funded Warrant [Member]
Datavault Pre-funded Warrant [Member]
Discount rate of FDA
Product Liability Contingency, Accrual, Discount Rate
Series A Common Stock [Member]
Series A Common Stock [Member]
Series A Common Stock [Member]
Investments
Investments, Total
Investments
Sale of Stock Percentage of Ownership before Transaction
Sale of Stock, Percentage of Ownership before Transaction
Additional Paid In Capital As Capital Contribution
Additional Paid In Capital As Capital Contribution
Additional paid-in capital as capital contribution
Long Term Debt Transactions [Axis]
Long Term Debt Transactions [Axis]
Document Annual Report
Document Annual Report
November Two Thousand Twenty Five Warrants [Member]
November Two Thousand Twenty Five Warrants [Member]
November 2025 Warrants [Member]
Business Combination [Axis]
Crypto Asset, Cost
Crypto Asset, Cost, Total
Digital assets, Cost Basis
Purchase Agreement Member
Purchase Agreement
Purchase Agreement
Shares issued under December Registered Direct Offering
Shares issued under December Registered Direct Offering
Shares issued under December 2024 RDO, Value
Initial Public Offering [Member]
IPO [Member]
IPO [Member]
Schedule of Accrued Expenses
Accrued expenses Textblock
Accrued expenses Textblock
Machinery and Equipment [Member]
Machinery and lab equipment [Member]
Shares issued under ESPP, shares
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Customer [Axis]
Payment to Oramed
Notes Payable, Noncurrent
Payment to Oramed
Tranche B Note [Member]
Tranche B Note [Member]
Tranche Note [Member]
Gain (Loss) on Disposition of Intangible Assets
Unrealized gain on digital assets
Unrealized loss on digital assets, net
Accounts and Other Receivables, Net, Current
Note receivable, net
Maximum [Member]
Maximum
Number of Treasury Stock transferred to Oramed for the Oramed Note maturity extension Shares
Number of Treasury Stock transferred to Oramed for the Oramed Note maturity extension Shares
Treasury Stock transferred to Oramed for the Oramed Note maturity extension, Shares
Debt Instrument, Increase (Decrease), Net
Debt Instrument, Increase (Decrease), Net, Total
Decrease in the debt balance
Forfeiture of Private Warrants
Forfeiture of Private Warrants
Forfeiture of Private Warrants
Total liabilities measured at fair value
Total liabilities measured at fair value
Liabilities, Fair Value Disclosure
Semnur Common Stock [Member]
Semnur Common Stock [Member]
Semnur Common Stock [Member]
Statistical Measurement [Axis]
Accumulated amortization
Finite-Lived Intangible Assets, Accumulated Amortization
Receivables, Net, Current
Receivables
Note receivable, net
Common Stock Value
Common Stock, Value, Issued
Common Stock Issued
Common stock, $0.0001 par value, 740,000,000 shares authorized; 8,491,267 shares issued and 7,033,004 shares outstanding as of March 31, 2026 and December 31, 2025
Net Income (Loss) Available to Common Stockholders, Diluted
Net Income (Loss) Available to Common Stockholders, Diluted, Total
Net loss for diluted loss per share attributable to common stockholders
Subsequent Penny Warrants 5 [Member]
Subsequent Penny Warrants 5 [Member]
Subsequent Penny Warrants 5 [Member]
Expiration date
Line of Credit Facility, Expiration Date
February 2024 BDO Firm Warrant [Member]
February 2024 BDO Firm Warrant [Member]
February 2024 BDO Firm Warrant
Sponsor Interest Purchase Agreement [Member]
Sponsor Interest Purchase Agreement [Member]
Sponsor Interest Purchase Agreement [Member]
Cash and Cash Equivalents [Abstract]
Payment for attorneys fees
Payments for Other Fees
Warrants and Rights Outstanding
Warrants outstanding
Equity, Including Portion Attributable to Noncontrolling Interest
Ending Balance
Begning Balance
Total Scilex Holding Company stockholders' deficit
Warrant Exchange Agreements [Member]
Warrant Exchange Agreements [Member]
Warrant Exchange Agreements [Member]
Consulting Agreement [Member]
Consulting Agreement Member
Consulting Agreement [Member]
Dorman Followwill [Member]
Dorman Followwill [Member]
Dorman Followwill [Member]
Related Party Transaction, Amounts of Transaction
Agreement amount
Related Party Transaction, Amounts of Transaction
Comprehensive loss:
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Aggregate Payment Of Company
Aggregate Payment Of Company
Aggregate Payment Of Company
Convertible Notes Payable
Convertible Notes Payable, Current
Notes Payable
December 2024 RDO Common Warrants [Member]
December 2024 RDO Common Warrants
December 2024 RDO Common Warrants [Member]
Securities Purchase Agreement [Member]
Securities Purchase Agreement [Member]
Securities Purchase Agreement [Member]
Securities Purchase Agreement
Lease liability, net of current portion
Lease liability, net of current portion
Lease liability, net of current portion
Accrued Liabilities
Accrued Liabilities
Accrued Liabilities, Total
Shares Issuable Under The ESPP [Member]
Shares Issuable Under The ESPP [Member]
Shares Issuable Under The ESPP [Member]
Estimated future amortization expense related to intangible assets
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
Accrued Payroll
Increase Decrease In Accrued payroll
Increase Decrease In Accrued payroll
Entity Public Float
Entity Public Float
Financing Receivable, Purchased with Credit Deterioration, Amount at Purchase Price, Total
Financing Receivable, Purchased with Credit Deterioration, Amount at Purchase Price
Purchase price for the purchased receivables
Derivative warrant liabilities
Derivative Warrant Liabilities
Derivative Warrant Liabilities
Expected volatility
Volatility
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Preference shares, authorized
Preferred Stock, Shares Authorized
Preferred stock
Interest Payable, Current
Accrued Interest
Royalty Expense
Royalty expenses
Royalty payments
Debt Instrument, Debt Default, Amount
Loan Agreement cumulative advances
Finite-Lived Intangible Assets by Major Class [Axis]
Shares Delivered
Shares Delivered
Shares Delivered
IPMC [Member]
IPMC [Member]
IPMC [Member]
Mergers, Acquisitions and Dispositions Disclosures [Text Block]
Acquisitions
ILeukon Intellectual Property License Agreement [Member]
ILeukon Intellectual Property License Agreement [Member]
iLeukon Intellectual Property License Agreement [Member]
Deferral and Consent under Tranche B Senior Secured Convertible Note [Member]
Deferral and Consent Under Tranche B Senior Secured Convertible Note [Member]
Deferral and Consent under Tranche B Senior Secured Convertible Note
Accretion of carrying value to redemption value
Temporary Equity, Accretion to Redemption Value, Adjustment
Payments for Deposits
Non-refundable deposit
Vivasor Subscription Agreement [Member]
Vivasor Subscription Agreement [Member]
Vivasor Subscription Agreement [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Disclosures [Abstract]
Accounts Payable and Other Accrued Liabilities
Accrued others
Payments for Purchase of Common Stock
Payments for Purchase of Common Stock
Payments for Purchase of Common Stock
Business Combination [Table]
Entity Registrant Name
Entity Registrant Name
Debt
Debt Disclosure [Text Block]
Sponsor and Legacy Semnur [Member]
Sponsor and Legacy Semnur [Member]
Sponsor and Legacy Semnur [Member]
Commitment Amount
Commitment Amount
Commitment Amount
Other Deferred Costs, Net, Total
Offering costs amount
Other Deferred Costs, Net
ZTlido Rest of World License Agreement [Member]
ZTlido Rest of World License Agreement [Member]
Tlido Rest Of World License Agreement [Member]
Entity Voluntary Filers
Entity Voluntary Filers
Customer Concentration Risk [Member]
Finite-Lived Intangible Asset, Expected Amortization, Year Two
2027
Payments to Acquire in Process Research and Development
Cash paid for in-process research and development, net
Additional Paid in Capital, Total
Additional paid-in capital
Additional Paid-in Capital
Additional amount borrowed
Additional Paid in Capital
Registration Rights Agreement [Member]
Registration Rights Agreement [Member]
Registration Rights Agreement
Subsequent Events [Abstract]
Finite-Lived Intangible Asset, Expected Amortization, Year Three
2028
Non Cash Revenue
Non Cash Revenue
Non- cash revenue
Debt Instrument, Percentage of Interest Accrued on Principal Amount
Debt Instrument, Percentage of Interest Accrued on Principal Amount
Debt instrument, percentage of interest accrued on principal amount
Proceeds from Issuance of Common Stock
Newly issued shares of Common Stock
Common stock aggregate purchase price
In Process Research And Development Amount Of Estimated Fair Value
In process research and development amount of estimated fair value.
In process research and development amount of estimated fair value
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Proceeds from sale of common stock
Proceeds from sale of common stock
Proceeds from sale of common stock.
Proceeds from sale of common stock
Entity Common Stock, Shares Outstanding
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Customer and Supplier Concentration Risk
Debt Repayment, Percentage of Mandatory Default Rate of Accrued and Unpaid Interest
Debt Repayment, Percentage of Mandatory Default Rate of Accrued and Unpaid Interest
Debt repayment, percentage of mandatory default rate of accrued and unpaid interest
Operating lease, remaining lease term
Lessee, Operating Lease, Remaining Lease Term
Descriptionof Organizationand Business Operations Details Table
Description of Organization and Business Operations (Details) [Table]
Paid to Royalty Investors
Paid to Royalty Investors
Paid to royalty investors
Accumulated other comprehensive income
Accumulated Other Comprehensive Income (Loss), Net of Tax
Accumulated Other Comprehensive Income (Loss), Net of Tax, Total
Schdule of Convertible Debentures
Convertible Debt [Table Text Block]
Clearing expenses
Clearing Expenses
Clearing Expenses
Development Milestone Payment
Fair value of contingent consideration
Fair value of contingent consideration.
Total assets
Total assets
Assets
Inventory, Policy [Policy Text Block]
Inventory
Property, Plant and Equipment [Table]
Registered Direct Offering [Member]
Registered Direct Offering [Member]
Registered Direct Offering
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Exercisable, Weighted-average Remaining Contractual Life, (in Years)
Income Statement [Abstract]
Income Statement
Two Thousand Twenty Two Employee Stock Purchase Plan [Member]
2022 Employee Stock Purchase Plan
Two Thousand Twenty Two Employee Stock Purchase Plan [Member]
Accrued rebates and fees
Increase (Decrease) in Accrued Rebates and Fees
Increase (Decrease) in Accrued Rebates and Fees
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Fair Value of Financial Instruments, Policy [Policy Text Block]
Fair Value Measurements
Legal Fees
Legal fees and expenses
Legal Fees and Expenses
Sale of Stock, Number of Shares Issued in Transaction
Number of Common Stock Shares Issued
Shares as Collateral
Shares as Collateral
Shares as Collateral
Shares issued, shares
Stock Issued During Period, Shares, New Issues
Aggregate shares issued, common stock
Preferred Stock Dividends, Shares
Preferred Stock Dividends, Shares
Secondary Purchase
Secondary Purchase
Vivasor - secondary purchase Three I Fund Agreement and Shah Agreement
Business Combination [Abstract]
Restructuring, Settlement and Impairment Provisions
Restructuring, Settlement and Impairment Provisions, Total
Carried Cost
Loss per share, Diluted
Earnings Per Share, Diluted
Diluted (Loss) income Per Share
Loss per share attributable to common stockholders - diluted
Non-cancelable Lease Agreements [Member]
Non-cancelable Lease Agreements [Member]
Non-cancelable Lease Agreements [Member]
Crypto Asset, Addition
Additions
Accounts payable
Increase (Decrease) in Accounts Payable, Trade
Title and Position [Domain]
Former Employee One[Member]
Former Employee One[Member]
City Area Code
City Area Code
Cash payment
Cash payment
Cash payment
Debt Instrument, Issued, Principal
Principle amount of issued debt
Business Combination, Consideration Transferred, Liabilities Incurred
Debt assumed (short-term and long-term)
Change in fair value of compound derivative upon extinguishment of Scilex-St.James Loans
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease)
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease), Total
Other comprehensive income
Total other comprehensive income
Total other comprehensive income
Other comprehensive income
Other Comprehensive Income (Loss), Net of Tax
Total other comprehensive income
Auditor Name
Auditor Name
Cash consideration paid in connection with share repurchase
Accelerated Share Repurchases, Adjustment to Recorded Amount
Retainer Shares [Member]
Retainer Shares [Member]
Retainer Shares
Debt Instrument, Fee Amount
Debt extension fees
Deposits
Deposits, Total
Ending Balance as of September 30, 2024
Ending Balance as of December 31, 2024
Reverse Stock Split
Reverse Stock Split
Reverse stock split
Initial principal amount
Debt Instrument, Face Amount
Debt principal amount
Summary of identifiable intangible assets
Schedule of Intangible Assets and Goodwill [Table Text Block]
Business Combination [Line Items]
Defined Benefit Plan [Table]
Shares issued under Standby Equity Purchase Agreements and under ATM Sales Agreement, Value
Shares issued under Standby Equity Purchase Agreements and under ATM Sales Agreement, Value
Shares issued under Standby Equity Purchase Agreements and under ATM Sales Agreement, Value
Schedule of Revenue by Major Customers, by Reporting Segments [Table]
Sale of stock, description
Sale of Stock, Description of Transaction
Operating Lease, Weighted Average Remaining Lease Term
Weighted average remaining lease term in years - operating leases
Percent of combined offering exercise price per share
Percent of Combined Offering Exercise Price Per Share
Percent of Combined Offering Exercise Price Per Share
Payment from Related Party
Payment from Related Party
Payment from Related Party
Warrant, Exercise Price, Increase
Stock exercise price
February 2026 Warrants [Member]
February 2026 Warrants [Member]
Company receives the FSF Deposit Amount
Company receives the FSF Deposit Amount
Company receives the FSF Deposit
Romeg License Agreement
License Agreement Terms [Member]
Business Combination, Recognized Liability Assumed, Financial Liability
Operating lease liabilities
Closing Penny Warrant [Member]
Closing Penny Warrant [Member]
Closing Penny Warrant [Member]
Award Date [Axis]
Cash and Cash Equivalents
Cash and Cash Equivalents, Policy [Policy Text Block]
Crypto Asset, Activity [Table Text Block]
Schedule of digital assets
Datavault AI Inc [Member]
Datavault AI Inc [Member]
Datavault AI Inc [Member]
Upside consideration - Aardvark shares claw back
Business Combination, Consideration Transferred, Equity Interest
Schedule of accrued rebates
Schedule of Accrued Rebates [Table Text Block]
Schedule of Accrued Rebates [Table Text Block]
Property and equipment, net
Property and equipment, net
Property, Plant and Equipment, Net
Pre-Funded Warrant [Member]
Pre-Funded Warrant [Member]
Pre-Funded Warrant [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
Vested and expected to vest as of March 31, 2026
Loss from operations
Loss from operations
Loss from operations
Operating Income (Loss)
Shares Issuable pursuant to ESPP [Member]
Shares Issuable pursuant to ESPP [Member]
Shares issuable under ESPP [Member]
Award Date [Domain]
Business Combination, Control Obtained, Description
Purchased Asset Terms
Current portion
Current portion
Debt, Current
Debt, Current, Total
Debt, current
Retained Earnings [Member]
Accumulated Deficit [Member]
Retained Earnings [Member]
Entity Address, Country
Entity Address, Country
Second Installment [Member]
Second Installment [Member]
Second Installment [Member]
Cash and Cash Equivalents [Axis]
Net tangible assets
Intangible Assets, Current
Transaction [Domain]
Semnur Merger Agreement And Sponsor Interest Purchase Agreement [Member]
Semnur Merger Agreement And Sponsor Interest Purchase Agreement [Member]
Semnur Merger Agreement And Sponsor Interest Purchase Agreement [Member]
Employee Benefits and Share-Based Compensation
Stock-based compensation
Share-Based Payment Arrangement, Noncash Expense
Share-Based Payment Arrangement, Noncash Expense, Total
Stock-based compensation
Stock-based compensation
Gloperba License Agreement [Member]
Gloperba License Agreement [Member]
Gloperba License Agreement [Member]
Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax
Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Total
Foreign currency translation adjustment
Percentage Of Royalties On Sales Payable Until Expiration Of Licensed Patent
Percentage of royalties on sales payable until expiration of licensed patent.
Percentage of royalties on sales payable until expiration of licensed patent
Principal Balance [Member]
Principal Balance [Member]
Principal Balance [Member]
Share Repurchase Program, Authorized, Number of Shares
Number of share repurchase
Datavault AI Warrants [Member]
Datavault AI Warrants [Member]
Non-Refundable, Non-Creditable Payment
Non-Refundable, Non-Creditable Payment
Non-Refundable, Non-Creditable Payment
October 2024 Note holder Warrants [Member]
October 2024 Noteholder Warrants [Member]
October 2024 Noteholder Warrants
Schedule of quantitative information regarding Level 3 fair value measurements
Fair Value, Concentration of Risk [Table Text Block]
Summery Of Inputs Used in Valuing The Derivative Warrant Liabilities
Accrued rebates
Accrued Rebates
Accrued Rebates
Weighted average discount rate - operating leases
Operating Lease, Weighted Average Discount Rate, Percent
Corresponding lease liabilities
Operating Lease, Liability, Noncurrent
Operating lease liabilities, net of current portion
Level 1 [Member]
Fair Value, Inputs, Level 1 [Member]
Disclosure Text Block [Abstract]
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Net cash proceeds from (used for) financing activities
Net cash provided by (used for) financing activities
Payment Related to Non Refundable Deposit
Payment Related to Non Refundable Deposit
Payment Related to Non Refundable Deposit
Schedule of Components of Lease Expense
Lease, Cost [Table Text Block]
Balance (in shares)
Treasury Stock, Preferred, Shares
Beignning balance. shares
Balance, ( In shares)
Auditor Location
Auditor Location
Schedule of the Oramed Note
Schedule of The Oramed Note Table Text Block
Schedule of The Oramed Note Table Text Block
Convertible Debentures and the Oramed Note [Policy Text Block]
Convertible Debentures and the Oramed Note
The Oramed Note, FSF Deposit and Tranche B Notes
Firm Warrants[Member]
Firm Warrants [Member]
Firm Warrants [Member]
Stock dividend declared, not yet distributed
Stock dividend declared, not yet distributed
Stock dividend declared in 2024, and canceled in February 2026
Nonoperating Income (Expense) [Abstract]
Other (income) expense, net:
Derivative liabilities
Derivative Liability, Noncurrent
Loan Agreement Amount
Loan Agreement Amount
Loan Agreement amount
Company Receives The FSF Deposit Period
Company Receives The FSF Deposit Period
Company Receives The FSF Deposit Period
Business Combination, Recognized Asset Acquired, Receivable, Current
Accounts receivable
Schedule of potentially dilutive outstanding securities were excluded from the computation of diluted net loss per share
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
VHC Business Combination [Member]
VHC Business Combination [Member]
VHC Business Combination
Business Combination, Recognized Asset Acquired, Investment in Debt and Equity Securities, Current
Marketable securities
Change in fair value of Convertible Debentures
Change in fair value of Convertible Debentures
Change in fair value of Convertible Debentures
Change in fair value of Convertible debentures
Change in fair value of Oramed Note - recorded in the consolidated statements of operations
Change in fair value of Oramed Note - recorded in the unaudited condensed consolidated statements of operations
Entity Interactive Data Current
Entity Interactive Data Current
Agreement maturity renewal description
Maturity Renewal Description
Maturity Renewal Description
Statement of Income Location, Balance [Domain]
VHC [Member]
VHC [Member]
Vivasor [Member]
Operating activities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Furniture [Member]
Furniture and Fixtures [Member]
Other accruals
Other Accruals
Other Accruals
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]
Payments To Settle Financing Arrangements Current
Payments To Settle Financing Arrangements Current
Payments to settle financing arrangements, current
Funding Commitment Letter [Member]
Funding Commitment Letter [Member]
Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares
Acquisition of share
Agreed to purchase Stock
Common Stock Issuable Value
Common Stock Issuable Value
Common Stock Issuable Value
FSF Warrant Purchase Agreement [Member]
FSF Warrant Purchase Agreement [Member]
FSF Warrant Purchase Agreement [Member]
Subsequent Penny Warrants 2 [Member]
Subsequent Penny Warrants 2 [Member]
Subsequent Penny Warrants 2 [Member]
Stock Issued During Period, Shares, Issued for Services
Stock issued for services, shares
Issuance of common stock in connection with Settlement Agreement, (in shares)
Entity Tax Identification Number
Entity Tax Identification Number
Options per share fair value
Share Price
Common Stock Share Price
Fair Value Of Warrants
Fair Value Of Warrants
Fair Value Of Warrants
Long-Term Debt, Type [Axis]
Transfer of Warrants
Transfer of Warrants
Transfer of warrants
Agilent Bio Loan Agreement [Member]
Agilent Bio Loan Agreement Member
Agilent Bio Loan Agreement
Numerator Abstract
Numerator:
NumeratorAbstract
Nature of Operations and Basis of Presentation
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Underwriting agreement, description
Other Commitments, Description
Aggregate amount payable under license agreements capped amount
Aggregate Amount Payable Under License Agreements Capped Amount
Aggregate amount payable under license agreements capped amount.
Effect of exchange rate changes on cash
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
ACEA Hangzhou
ACEA Hangzhou [Member]
ACEA Hangzhou Member.
Proceeds from Issuance or Sale of Equity
Proceeds from Issuance or Sale of Equity, Total
Proceeds from sales of stock
Local Phone Number
Local Phone Number
Related Party Transaction [Domain]
New Tranche B Warrants [Member]
New Tranche B Warrants [Member]
New Tranche B Warrants [Member]
Debt Securities, Realized Gain (Loss)
Debt Securities, Realized Gain (Loss), Total
Realized loss on securities
Realized loss on securities
Two Thousand Twenty Three Inducement Plan [Member]
Two Thousand Twenty Three Inducement Plan [Member]
2023 Inducement Plan
Other Liabilities, Current
Total accrued rebates and other sales-related accruals
Other accruals
Other current liabilities
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Unrecognized compensation cost related to unvested stock option grants
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Weighted average number of shares during the period basic & diluted
Warrants Issuance Costs
Warrants Issuance Costs
Issuance of February 2026 Warrants
Datavault License Agreement [Member]
Datavault License Agreement [Member]
Revenue, Remaining Performance Obligation, Percentage
Revenue, Remaining Performance Obligation, Percentage
Loan Agreement interest rate terms
Line of Credit Facility, Interest Rate Description
Stock Purchased During Period Value
Stock Purchased During Period Value
Stock Repurchased
Warrants Received
Warrants Received
Warrants received
Voting Stock Outstanding Percentage
Voting Stock Outstanding Percentage
Voting Stock Outstanding Percentage
Accounting Policies [Abstract]
Debt Instrument, Convertible, Threshold Trading Days
Trading Days
As Previously Reported [Member]
Previously Reported [Member]
Value Issued Under Placement Agent Warrants Issued In Connection With Registered Direct Offering And Representative Warrants Issued In Connection With Bought Deal Offering
Value Issued Under Placement Agent Warrants Issued In Connection With Registered Direct Offering And Representative Warrants Issued In Connection With Bought Deal Offering
April 2024 RDO Placement Agent Warrants issued in connection with April 2024 RDO and February 2024 BDO Representative Warrants issued in connection with February 2024 BDO
ChangeInValuationInputsOrOtherAssumptions
Change in fair value measurement
Change in valuation inputs or other assumptions.
Change in fair value measurement
Change in fair value due to credit risk
Change In Fair Value Due To Credit Risk
Change In Fair Value Due To Credit Risk
Lessee, Operating Lease, Liability, to be Paid, Year Four
2030
Repayment of purchased revenue liability
Repayment of purchased revenue liability
Repayment of purchased revenue liability
Debt Instrument, Repurchased Face Amount
Amount received in exchange for issuance of the New Notes
Debt Instrument Repurchased Face Amount
Class of Stock [Domain]
Number of shares available for grant
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Accrued Professional Fees, Current
Accrued professional service fees
Vivasor Datavault License Agreement [Member]
Vivasor Datavault License Agreement [Member]
Vivasor Business Combination [Member]
Vivasor Business Combination [Member]
Vivasor Business Combination [Member]
Entity Emerging Growth Company
Entity Emerging Growth Company
Number Of Warrants Exercised 1
Number Of Warrants Exercised 1
Number Of Warrants Exercised
Oramed [Member]
Oramed [Member]
Oramed [Member]
Indefinite-Lived Intangible Assets [Axis]
Warrant Inducement Agreement
Warrant Inducement Agreement [Member]
Warrant Inducement Agreement [Member]
Total purchase consideration
Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill
Goodwill excess of the purchase consideration over the fair value